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The overall aim of this thesis is to investigate the potential biomedical applications of multi-
dimensional high-aspect ratio nanomaterials. 
  





In the first part, the thesis provides a general introduction on the importance of materials 
science to our daily life. Particular attention is devoted to the biomedical applications of high-
aspect ratio nanomaterials such as carbon-derived multi-dimensional nanomaterials 
(fullerene, zero-dimension; carbon nanotubes, one-dimension; graphene and graphene oxide, 
two-dimension; graphite and diamond, three-dimension) and polymer-modified inorganic 
metal nanoparticles, i.e. gold nanorods. 
 
Part II 
The second part includes two chapters that deal with protein adsorption to high-aspect ratio 
carbon-derived nanomaterials, including One-Dimensional Carbon Nanotubes and Two-
Dimensional Graphene Oxide Nanosheets. 
Part II - chapter 1  
In the first chapter, carboxylic acid functionalized carbon nanotubes (CNTs-COOH) from 
different commercial sources will be evaluated. Ultra-sonication and tannic acid as a low 
toxicity dispersant will be tested to obtain stable CNT suspension that can further be used for 
protein adsorption. 
Part II - chapter 2  
The second chapter aims at the synthesis of water-soluble graphene derivative, i.e. graphene 
oxide nanosheets(GOx), that combines high-aspect ratio dimensions with hydrophilic 
functional groups such as hydroxyl and carboxyl groups. These GOx nanosheets will be 
investigated for their ability to adsorb the model protein antigens. Finally, we will investigate 
the interaction between antigen-adsorbed GOx nanosheets and dendritic cells in vitro.  
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Part III - chapter 3 
Part III of this thesis will investigate another type of high-aspect ratio nanomaterials, i.e. gold 
nanorods, that can be combined as an external light trigger to generate heat and induce 
phase transformation of a transiently thermo-responsive polymer. For this purpose, a 
synthetic bio-degradable polymer with upper critical solution temperature (UCST) behavior 
will be developed. 
 
In addition to the research chapters, this doctoral dissertation provides a prominent section 
to discuss the scientific findings in view of the broader international context of the conducted 
research and the future developments to be expected in this field. Additionally, this thesis 

























Today, with the steady increase of our material life, from the basic necessities to the study of 
science and technology, we have become inseparable from materials and materials science. 
Even for the major historical periods of our society, we assorted them as stone age, bronze 
age, steel age (the industrial revolution) and polymer age, etc.. As the 21st century unfolds, 
we are not only striving to understand and modify the world around us but also looking 
forward to a better understanding, optimizing and application of advanced materials.  
 
 
Figure 1. Structural hierarchy of the gecko adhesive system. From macrostructure (A,B) to 
microstructure (C,D, and E). [1] 
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By suggesting the development of molecular machines, the seminal idea of “nanotechnology” 
was first proposed by Richard Feynman  at the meeting of the American Physical Society in 
1959.[2] The concept of “Nano” was then widespread used in most of the modern sciences. 
Decreasing the size into the nanoscale or assembling materials at nanoscale lead to a 
dramatic increase in the surface area, surface roughness and surface area to volume ratios 
which are important parameters that instigate material bulk properties.[3] Also in nature, 
many existing materials are nano-scaled such as cells, bacteria and viruses. Even some seem 
smooth materials to the naked eye, have intricate structures at the nanoscale, as shown in 
Figure 1.[1] The term ‘‘nanotechnology’’ was first used in a scientific publication “On the Basic 
Concept of 'Nano-Technology”  authored by Norio Taniguchi in 1974.[4] Thereafter, in parallel 
with the emergence of nanotechnology, the research on nanomaterials has also grown 
exponentially in the fields of materials science, biological and chemical science, biomedicine 
and drug delivery, etc..  
Nanomaterials, in principle can have any shape (e.g. nanoparticles, nanotubes, quantum dots, 
nanowires, nanofibers or nano-rods) and at least one dimension, including internal structure 
or surface structure, sized below 1000nm.[5] Although this field was in its relative infancy 
decades ago, at present, nanomaterials have already been used in a wide range of products 
such as sunscreens, composites, catalysts and medical devices.  
Comparing to the same material without nanoscale features, nanomaterials are developed to 
exhibit particular size and shape dependent properties such as unique optical, chemical 
reactivity, electronic conductivity and mechanical properties which are primary caused by 
surface and quantum effects.[6, 7] As nanomaterials are sufficiently small to confine their 
electrons and produce quantum effects, they often possess unexpected visual properties. For 
instance, different sizes gold nanoparticles appear deep red to black in solution.[8, 9] In the 
meantime, nanomaterials are also considered to be a bridge between bulk materials and 
atomic or molecular structures.[10] Today, we can easily synthesize a large amount of pure 
single composition nanomaterials but the ones that are found in nature are often 
agglomerated and with various compositions. Depending on the size of the agglomerate 
which is often occurred between the nanoscale materials, nanoparticles may behave as larger  
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entities. [11, 12] 
In the past, the general tendency was to consider all nanoparticles as being spherical in shape. 
However, since the advent of fibre toxicology of asbestos,[13] high-aspect ratio nanomaterials 
with a length many times of their width have attracted widespread attention by nanomaterial 
scientists. These fiber-like nanostructure can induce toxicity by casing lysosomal damage.[14] 
As a growth area in nanotechnology, elongated materials with nanometer length scales such 
as nanorods, nanowires, and nanotubes often result in inherent chemical, electrical, optical 
and magnetic anisotropy which make them attractive for biomedical applications.[13, 15, 16] 
Given their unique elongated shape, high-aspect ratio nanomaterials could interact with cells 
and biomolecules in fundamentally new ways.[17] By introducing multiple targeting units on 
their surface, one could enable multivalent interactions with receptors to enhance cellular 
internalization.[18, 19] Additionally, due to the magnetic anisotropy, high-aspect ratio 
nanomaterials could be used as improved contrast agents compared to their spherical 
analogues for the magnetic resonance imaging (MRI) applications.[20, 21] Both the length as 
well as aspect ratio of  high-aspect ratio nanomaterials play significant roles in their biological 
reactivity. Zhaoxia Ji and coworkers found that at lengths >200 nm and aspect ratios ≥ 22, 
CeO2 nanorods induced progressive pro-inflammatory effects and cytotoxicity in vitro.[14] In 
comparison, small nanorods or nanowires diameters (6-10 nm) with relatively low “critical” 
length and aspect ratio often possess strong van der Waals and dipole-dipole attractions 
which result in the formation of stacking bundles. The two main synthetic strategies for the 
preparation of the high-aspect ratio nanomaterials are often classified as direct synthesis and 
assembly method.[22-24] For the former route, tuning the reaction conditions or using 
templates could induced anisotropic growth. While, for the later assembly method, the 
anisotropy is achieved by assembly from individual building blocks. 
However, it is worth to point out that each material has its own advantages and 
disadvantages. Nanomaterials can offer exceptional new properties while also show signs of 
toxicity. Due to their small size, smaller than most of the cells and cellular organelles, they are 
clearly associated with health risks, some happened to be toxic to biological systems, some 
are relatively benign, while others confer health benefits.[5, 25-28] However, these toxic 
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properties of nanoparticles may be beneficial for medical diagnostics and treatment, as they 
are thereby able to fight disease at the cellular level, and hold potential of altering the 
interaction between therapeutic molecules and target cells or tissues to destroy cancerous 
cells. For example, chemical-functionalized fullerene can act as antioxidants[29, 30]. Carbon 
nanotubes and gold nanorods, the best known and studied of high-aspect ratio nanomaterials, 
owing to their fibrous shape with different nano-sized diameters, have the potential for 
human inhalation exposure.[14, 31, 32] 
Therefore, to limit the adverse health impacts of nanomaterials and drive their safety as well 
as utility to be better used in our biomedical applications, particular intelligent design and 
development of nanomaterials are urgently needed. Bearing this in mind, this thesis is 
focused on the biomedical applications of some high-aspect ratio nanomaterials such as 
carbon-derived multi-dimensional nanomaterials and polymer-modified inorganic gold-
nanorods.  
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Carbon-Derived Multi-Dimensional Nanomaterials 
Carbon, a very common element which comes from the Latin carbo for “coal and charcoal”,[33] 
is almost present everywhere in our universe such as atmosphere, crust and living organisms. 
By mass, it is the fourth most abundant element after hydrogen, helium, and oxygen in the 
universe and the second in our human body (about 18.5%) after oxygen.[34] Carbon has long 
been known and used, the earliest human civilizations known of carbon was in the forms 
of soot and charcoal in prehistory. In 1789, Antoine Lavoisier listed carbon as a chemical 
element with symbol C in the Periodic table of elements IV A.[35, 36] This element can form 
bonds by itself and has the ability to arrange and rearrange its atoms in chains and rings. The 
different ways carbon atoms arrange leads the different carbon substances.[37, 38] The use of 
carbon is almost unlimited for it is capable to be very soft as graphite or very hard as 
diamond.[39, 40] Therefore, the utilizing of carbon and its allotropes (the material is made of a 
pure substance or element with a few differences in atom formation) has grown exponentially 
in almost all of the industrial and academic fields.[41-43] 
 
Figure 2. Schematic structures of zero-dimensional material (0D), Fullerene(A); one-dimensional 
material (1D), Carbon Nanotube(B); two-dimensional material(2D), Graphene (C); and three-
dimensional materials(3D), Graphite(D) and Diamond(E). 
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In the 20th century, a series of exciting carbon-based nanomaterials are arising. Taking the 
number of their dimensions into account, carbon-derived nanomaterials could be classified, 
as shown in Figure 2., from zero-dimensional materials (0D) like fullerene to one-dimensional 
materials (1D) (including carbon nanowires, nanotubes and nanofibers), two-dimensional 
materials (2D) such as graphene and graphene oxide and three-dimensional materials (3D) 
which are rich in nanostructures but exceed the nanoscopic size in all of the three 
dimensions.[39] Their nano-level size and unique structures result in excellent mechanical 
strength, electrical and thermal conductivity, and optical properties. All of these 
advantageous properties have attracted tremendous attention and much of the research 
efforts have been focused on their utilizing. Additionally, due to their multi-functional nature, 
carbon-derived nanomaterials are regarded as highly attractive biomaterials for biomedical 
applications and breakthroughs.   
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Zero-dimensional (0D) carbon-derived nanomaterials.  
Zero-dimension (0D) starts form a point which is viewed as a geometric point. It has no size, 
no time and no dimension. Materials which are nano-scaled in all three dimensions are 
considered zero-dimensional (0D) nanomaterials including atomic-scale porosity, colloids, and 
free nanoparticles with various morphologies. 
Fullerenes, as their sphere structure, caged molecules and nanometer-scale diameter 0.7 nm, 
are classified as  zero-dimensional (0D) carbon-derived nanomaterials.[39] The first fullerenes 
molecule C60 was discovered by serendipity during laser spectroscopy experiments in 1985[44] 
and the discoverers Robert Curl, Harold Kroto and Richard Smalley received the Nobel Prize in 
Chemistry “for their discovery of fullerenes” in 1996.[45] These convex polyhedrons are 
composed of pentagonal and hexagonal surfaces.  The discovery of fullerenes greatly 
expanded the number of known carbon allotropes include hollow sphere, ellipsoid, tube, and 
many other shapes such as buckyballs (C60) and buckytubes (carbon nanotubes).[44, 46, 47] 
Fullerenes have been found not only in nature but  also in the outer space.[48, 49] The smallest 
fullerene is a regular dodecahedron molecule C20.[50] In the last two decades, a lot of research 
groups have contributed to this field to produce fullerenes and their derivatives in a mild and 
mass yielded method.[47, 51-56] 
Buckyball (C60) and its derivatives, owing to their lower cost and easy purification, are the 
most common and compelling zero-dimensional (0D) nanomaterials in the field of research 
and applications.[59-61] Fullerenes have been the subject of intense research for their unique 
chemistry and technological applications, especially in materials field, electronics, and 
nanotechnology.  
Fullerenes are chemical stable and sparingly soluble in many solvents such as toluene and 
chlorobenzene, but not totally unreactive. A chemical reaction to which they are often 
subjected is electrophilic addition at 6,6-double bonds, which reduces angle strain by 
changing sp2-hybridized carbons (120°) into sp3-hybridized ones (109.5°). Some fullerenes (e.g. 
C76, C78, C80, and C84) are inherently chiral for their D2-symmetric and research efforts have 
been devoted to the development of specific sensors for enantiomers.[57, 58]  
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Haddon and coworkers found that alkali-doped C60 exhibit superconductivity. [59] For example, 
in 1991, the potassium-doped C60 superconducting behavior at 18K was the highest molecular 
superconducting temperature to be found. Since then, a large amount of metal-doped 
fullerene superconductors have been identified. The superconducting conversion 
temperature will rise with the increase of the unit cell volume of alkali-doped fullerenes. 
Fullerenes have also been extensively used for biomedical applications such as the design of 
high-performance MRI and X-Ray imaging contrast agents, photodynamic therapy, drug and 
gene delivery.[60] Although cancer radiotherapy has been used for many years in the clinic,[61-
65] photodynamic therapy is gaining increase popularity. 
The solubility of fullerenes can be increased by functionalization with L-phenylalanine, folic 
acid, and L-arginine. [62, 63] When internalized by cancer cells and exposed to light radiation, 
C60-derivatives can transform molecular oxygen into reactive oxygen which could trigger 
apoptosis of these cancer cells and minimize the damage to surrounding tissues. Once the 
light radiation treatment is finished, the fullerenes will reabsorb the free radicals to prevent 
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One-dimensional (1D) carbon-derived nanomaterials.  
One-dimension (1D) space is like a line between two points which only has length but no 
width or depth. One-dimensional (1D) nanomaterials are materials with two dimensions in the 
nanometer scale, including nanowires, nanotubes, nanobelts and nanorods which have a 
high-aspect ratio and large surface area.[66]  
Carbon nanotubes (CNTs) are cylindrical fullerenes, a new more deliberately fabricated "one-
dimensional" type of crystalline carbon nanoparticles that can be envisioned as rolled 
graphene.[67] The first important discovery of carbon nanotubes (CNTs) which brought them 
into the awareness of the scientific community was in 1991 by Lijima.[68] Since then, CNTs 
represent a new class of technological nanomaterial with innovative and unique electrical, 
optical and mechanical properties including their large surface areas and superior bundle 
strength[69-71] which make them suitable for many applications in biomedicine and 
pharmacology. To date, CNTs are still one of the most powerful one-dimensional 
nanomaterials in the world. In the meantime, CNTs possess a broad field of applications, 
including energy conversion, quantum nanowires, catalyst supports, etc.. 
Depending on the number of graphene layers, CNTs are classified as single-wall carbon 
nanotubes (SW-CNTs)[72-76] and multi-wall carbon nanotubes (MW-CNTs).[68, 77, 78] Additionally, 
based on the morphology, there are also some other types of CNTs such as end-closed and 
end-opened carbon nanotubes, carbon nanobuds, carbon peapod, graphenated carbon 
nanotubes and extreme carbon nanotubes which could improve the composite’s mechanical 
or chemical properties.[79-86] 
As be envisioned as rolled graphene, CNT) could have different properties by the different 
rolling angles and curvatures.[87, 88] But unlike graphene being semimetal, CNTs are either 
semiconducting or metallic along the tubular axis.[89] CNT are only few nanometers wide, but 
in length can range from micrometers to millimeters. Measured for their tensile strength and 
elastic modulus, CNT are the strongest and stiffest materials,[90-92] but by Young's modulus, 
they are in fact very soft in the radial direction.[93-95] CNTs are good thermal conductors along 
the tube but insulators lateral to the tube axis. Additionally, the quality of CNTs can be 
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changed by numerous synthesis parameters intentionally or unintentionally which could be 
characterized by their absorption, photoluminescence (fluorescence), and Raman 
spectroscopy properties. Related to the typical nanomaterials, all of the properties of CNTs 
are anisotropic (directionally dependent) and tunable which are favorable for various 
applications. 
CNTs can be functionalized to equip them with specific properties. Covalent reactions and 
non-covalent coating are the two main methods for CNTs functionalization.[77, 96-102] CNTs are 
hydrophobic and trend to agglomerate and sediment in water due to strong Van der Waals 
interaction forces along their length axis.[90, 91, 96, 103-105] The bundles or aggregates of CNTs can 
reduce the final composite’s mechanical performance. Also the CNT surface can be modified 
to reduce the hydrophobicity and improve interfacial adhesion. [106, 107] 
The quality of CNT can be quickly and non-destructively characterized by its special 
absorption, photoluminescence (fluorescence), and Raman spectroscopy properties.[108-110] 
Furthermore, based on the CNT anisotropic (directionally dependent) and tunable properties, 
they are potentially useful in optics and photonics, especially for light-emitting diodes 
(LEDs)[111, 112] and photo-detectors.[113] Their narrow selectivity in the wavelength of emission 
and detection of light have already been used in bolometer and optoelectronic memory 
devices.[114, 115] Compared to copper which is well known for its good thermal conductivity 
(transmits 385 W•m−1•K−1), CNTs have a higher room-temperature thermal conductivity 
along its axis (transmits 3500 W•m−1•K−1).[116] 
Thanks to the high surface area[17, 87, 103, 117] and rich electronic poly-aromatic structure, CNTs 
are able to adsorb or conjugate to a wide variety of therapeutic and diagnostic agents (drugs, 
genes, DNA, enzymes, vaccines, antibodies, biosensors, etc.).[97, 118-121] Furthermore, they 
have been explored as a vehicle for drug delivery by directly penetrating the cells membrane 
or even nuclear membrane,[122-124] and keeping the drug intact during transport. Compared to 
traditional methods, agents linked to CNTs  can be delivered more safely into cells which open 
a new way for drug formulation.[67, 125]  
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The state-of-art progress on the potential applications of CNT have excited the interest of 
scientists in fields of pharmacy and medicine, not only for drug and gene therapies[126, 127] but 
also for immunotherapy, tissue regeneration, catalyst supports, enantiomer separation of 
chiral drugs and diagnosis of different ailments.[67, 128-130] 
By the high Van der Waals interaction forces along the length axis, CNTs  are hydrophobic and 
trend to agglomerate and sediment in water.[125, 131] Therefore, CNTs must be functionalized 
(covalent reactions and non-covalent coating by amphiphilic molecules) to afford water 
solubility and biocompatibility in view of biomedical applications. Addition of dispersants such 
as sodium dodecyl sulfate (SDS), Triton X-100 and polyvinyl pyrrolidone (PVP)[127, 132] could 
help to stabilize CNTs  suspensions but if the excess of stabilizing molecules are removed 
these carbon nanotubes will aggregate and deposit. The ideal CNT for biomedical applications 
should have high water solubility, good biocompatibility, stable nanotube structure and 
functional groups for further bio-conjugations. [77] Given their unique structural features and 
outstanding properties, in the near future, CNTs will find broad applicability in a wide variety 
of disciplines both for industry and academic. 
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Two-dimensional (2D) carbon-derived nanomaterials. 
If we draw a rectangle on paper, the inside of this rectangle will look like a two-dimensional 
(2D) space. The objects in two-dimensional space have a width and a length, but no depth. 
Two-dimensional (2D) nanomaterials have only one dimension in the nano-scale such as 
ultrathin 2D nano-films and surface coatings. The lateral size of these sheet-like structures is 
larger than 100 nm while the thickness is only single- or few-atoms thick, so called 
monolayers. In the past decade, given their unique structural features, the research area of 
ultrathin 2D nanomaterials has led to an emerging class of nanomaterials and has grown 
exponentially in the fields of condensed matter physics, material science, chemistry, and 
nanotechnology.  
Graphene and Graphene oxide (GOx)  
As one of the most famous ultrathin two-dimensional (2D) carbon-derived nanomaterials in 
the 21th century, graphene,[39, 133] a two-dimensional single layer of carbon atoms like 
hexagonal lattice, is named by Hanns-Peter Boehm as a combination of "graphite" and the 
suffix ‘ene’ in 1962.[134, 135] It was originally observed on metal surfaces by electron 
microscopy. Graphene was discovered by Andre Geim and Konstantin Novoselov in 2004 at 
the University of Manchester[136] and  awarded the 2010 Nobel Prize in Physics.[137, 138]   
 
 
Figure 3. Schematic structures of Graphene (A) and Graphene oxide (B). 
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Graphene can be considered as a flat "infinite alternant" polycyclic aromatic hydrocarbon 
composed of six-member carbon rings. Due to its tightly packed carbon atoms and the sp2 
orbital hybridization, graphene has several exciting chemical and mechanical properties.[139-142] 
For example, it is a semi-metallic or zero-gap semi-conductor.[143] Although the theoretical 
thickness of graphene is only 0.335 nm and it is nearly transparent to visible light, it is  about 
200 times stronger than the strongest steel.[144, 145] Furthermore, graphene can be modified 
with oxygen- and nitrogen-containing functional groups. 
The research into its applications includes solar cells, light-emitting diodes (LED), the touch 
sensor in touch panels and smart windows or phones.[146, 147] In addition, graphene and 
modified graphene have also been applied in the biomedical field as they could pierce the cell 
membranes via sharp and jagged points.[148] Meanwhile, the shape, size, purity and the dose 
of administration or exposure times of graphene determines its toxicity.[149, 150]  
Moving on from the graphene, its oxidation derivative, the water-soluble graphene derivative 
graphene oxide (GOx) [151-153]has also been explored for a wide range of potential applications. 
Figure 3. shows the schematic structures of graphene and graphene oxide. 
Graphene oxide (GOx) is the single-layer form of graphite oxide which was first prepared by 
Oxford chemist Benjamin C. Brodie in 1859.[154] And then in 1957, the famous Hummers' 
method, a much safer, quicker, and more efficient process was developed by Hummers and 
Offeman.[151] Graphite powder was reacted with the strong oxidizing agents potassium 
permanganate (KMnO4), concentrated sulfuric acid (H2SO4) and sodium nitrate (NaNO3). 
Exactly, "oxide" is an incorrect but historically established name. GOx is known for its 
particularly high-aspect ratio and surface area which is almost 10-fold of other nanomaterials 
and favorable for various applications. This planar structure, with a 2D atomic layer composed 
of crumpled sheets of sp2- and sp3- hybridized carbon atoms,[155-158] is enriched with epoxides, 
hydroxyls (-OH) and carboxylic acids  (-COOH) functional groups.[159-162] The thickness of GOx 
layers are about 1.1 ± 0.2 nm but the detailed structures are still unclear due to the strong 
disorder and irregular packing of the layers.[163, 164] 
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Owing to all of the aforementioned unique structures and functional groups, GOx is 
hydrophilic.[165] It can be easy dispersed in water and other organic solvents, and it is a good 
surfactant material to stabilize various emulsion systems. Once removing most of the 
functional oxygen groups, the reduced graphene oxide (R-GOx) is tended to aggregate and 
more difficult to disperse.[166, 167]  
For a long time, graphite oxide, i.e. multilayered GOx, has attracted much interest as a 
possible route for the large-scale production and manipulation of graphene at a low cost. 
Being hydrophilic, graphite oxide can be easily dispersed in water, breaking up into 
macroscopic flakes, mostly one layer thick GOx. The reported interlayer distance in dried state 
of graphite oxide is about 6-7 Å while in water it increases to about 11-13 Å at room 
temperature. However, it is difficult to mass produce graphene sheets with the same quality 
by mechanical exfoliation.[168] Different qualities of the precursor, GOx, and different chemical 
reductions may lead to graphene sheets of different qualities.[169-173] In the future, if this issue 
could be overcome, we can expect a much more widely used of graphene in medical, 
commercial and industrial applications.  
The first reports on biomedical applications of graphene and GOx as nanocarrier for drug 
delivery have emerged in 2008 by Dai and co-workers.[174] They functionalized GOx 
nanosheets with branched polyethylene-glycol (PEG) to obtain a biocompatible GOx-PEG 
conjugate which is stable in various biological solutions and could be used for attaching 
hydrophobic aromatic molecules. Since then, a lot of work has been carried out to explore the 
use of graphene and GOx in the biomedical field, from drug/gene delivery, antibacterial 
materials, biological sensing and imaging to cancer therapy, and biocompatible scaffolds for 
cell culture.[175-178] For example, GOx with a size of a few hundreds of nanometers in the 
planar direction, can destabilize the membrane of bacteria[122, 123, 148] which could render GOx 
an attractive nano-carrier for intracellular delivery of therapeutic molecules.[179, 180] Utilizing 
the intrinsic near-infrared (NIR) optical absorbance, the GOx can be applied photothermally 
for antitumor treatment.[181, 182] 
In addition, the theoretical load of GOx is up to 200%, for both sides of it have aromatic 
structures and oxygen-containing functional groups that can be used for covalent and non-
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covalent modification by van der Waals force, π-π conjugation, hydrophobic effects, hydrogen 
bonding and electrostatic interaction.[155-157]  
GOx can be fundamentally changed by functionalization and used for multiple applications.[153, 
183, 184] For example, introduction of amines could increase its dispersibility in organic solvents. 
GOx nanosheets can spontaneously adsorb proteins by a combination of interactions without 
the requirement of additional reagents.[165] After that, the GOx nanosheets adsorbed proteins 
could efficiently destabilize the lipid membranes and be internalized by dendritic cells then 
promote antigen cross-presentation to CD8 T cells[122, 148, 165] which is a hallmark in the 
induction of potent cellular antigen-specific immune responses against intracellular 
pathogens and cancer. 
Without a doubt,  the current research on two-dimensional (2D) nanomaterials has prompted 
several exciting developments, but most still remain to be explored in more depth and far 
from the criteria which are required for industry or commercialization, especially those 
beyond Graphene and Graphene oxide(GOx) such as Hexagonal Boron Nitride(h-BN),[185-187] 
Graphitic Carbon Nitride(g-C3N4)[188] and Transition Metal Dichalcogenides(TMDs)[189, 190]. 
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Three-dimensional (3D) carbon-derived nanomaterials.  
The space which we all live in, with length, width and height, is the three-dimensional (3D) 
space. In another word, bending the two-dimensional space, we could get a three-
dimensional space. 
Owing to the different array of carbon in each matter, carbon could produce the softest 
material (Graphite) and the hardest substance (Diamond). 
Graphite is an allotrope of carbon aside from diamond and amorphous carbon which means it 
is one of carbon’s pure forms with its atoms arranged in big sheets of hexagonal rings.[191, 192] 
This block form of graphene, has a layered, planar structure and can be easily broken down. 
[191] Under standard conditions, graphite is the most stable form of crystalline of carbon. 
Diamond, is one of the highest hardness and oldest materials found on earth.[193, 194] The 
natural diamond is irregular in shape and its formation requires very specific conditions like 
high temperature (900 to 1,300 °C), high pressure (45 to 60 kilo bars) and at depths of 140 to 
190 kilometers in the Earth's mantle.[195] Because of the strength and directionality of sp3 
hybrid carbon bonding, diamond is the hardest natural substance so to speak.[196, 197] The 
element carbon arranged in a tetrahedral crystalline fashion, each carbon atom is 
surrounding with four neighboring carbon atoms with strong covalent bonding between them 
which is a fancy way of describing the state of covalent bonding in carbon.[198, 199] 
 
  




Polymer Modified  Inorganic Metal Nanomaterials 
--- The gold nanorods with Poly(HPMA-
Glycolamide) 
Gold (with symbol Au in the periodic table), is one of the most inert chemical elements and a 
transition metal element.[200] To date, gold is still a popular noble metal[201, 202] and precious 
material used for money, jewelry[203, 204] and arts,[205-207] due to its relatively scarce, unique 
color and corrosion resistance.[208, 209] Given all of the aforementioned unique properties, gold 
has mainly been utilized as corrosion-resistant electronic connectors in all types of electronic 
equipment.[210] Additionally, it is also developed to shield infrared, produce colored glass and 
gold foil.[211] In medicine, gold is often used to repair teeth, and some gold salts can be 
exploited as anti-inflammatory agent.[212-215] The properties of colloidal gold, i.e. suspensions 
of gold nanoparticles (1 to 100 nm),  strongly depend on both nanoparticles size and 
shape.[216] High-aspect ratio (length divided by width) gold nanoparticles, in particular gold 
nanorods (AuNRs), are attractive for a range of biomedical applications, due to their modular 
functionality and anisotropic structural, optical, electronic, magnetic and catalytic properties. 
[217-221]   
Fabrication of AuNPs is dated back to 1857 by Faraday while the synthesis of colloidal AuNRs 
emerged only during the past decade.[222, 223] Several strategies for AuNR synthesis have been 
reported and comprise both bottom-up and top-down approaches.[229, 254-256] To date, the 
one-step seedless method and the seed-mediated growth method are two of the most simple 
and reproducible bottom-up techniques. 
In the one-step seedless method, sodium borate is directly added to the growth solution in 
the presence of ascorbic acid, cetyltrimethyl ammonium bromide (CTAB) as surfactant and 
silver ions to initiate particle nucleation and growth.[224] Changing the amount of sodium 
borate or adjusting the reaction temperature can control the aspect ratio of the obtained 
nanorods. In the meantime, the seed-mediated growth method is originated in 2001 by Jana 
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et al.[221] AuNRs were prepared by the addition of citrate-capped small gold nanospheres to a 
bulk HAuCl2 growth solution which was obtained by the reduction of HAuCl4 with ascorbic acid 
in the presence of CTAB as surfactant and ions.[225] The introducing of silver ions (lower 
reduction potential than gold) to the growth solution could help ascorbic acid to reduce gold 
ions into metallic gold as a catalyst for the reduction reaction. Furthermore, a three-step 
procedure in the absence of silver nitrate was proposed by the same group for the synthesis 
of AuNRs with an aspect ratio of 25.[221, 225-227] In this typical procedure, first-stage AuNRs 
were used as seeds for second growth, and sequentially be used as seeds for the next growth. 
Finally, simple centrifugation can be used to stop the overgrowth and remove the free CTAB. 
With slight modifications in the preparation conditions (eg. carefully control of the solutions 
temperature, stirring speed, ratio of seed to metal salt, etc…), the aspect ratio of the AuNRs 
can be tuned. In the growth solution, the amount of ascorbic acid mainly influences how 
many gold ions will be reduced, and the number of seeds determine how to divide the 
intrinsic growth rate in width and length.   
Alongside, CTAB can promote the growth of gold seeds in one dimension to produce rods and 
provide their surface with a positive surface charge which prevents the  aggregation in water 
via electrostatic repulsion.[228-230] Due to the affinity of thiols for gold, CTAB can also be ion-
exchanged with other sulfur-containing compounds. The growth at the ends of AuNRs can be 
further tuned by changing the amount of silver nitrate or the reaction temperature. Silver 
ions do not directly influence rod length or width.[231] However, freshly prepared silver nitrate 
and ascorbic acid solutions are also important for good yield and high shape purity mono-










Figure 4. Schematic structures of AuNRs. (A, B) Two possible cross-sections of the AuNRs and the 
corresponding profiles of crystal thickness variation across the rods. (C) A structural model of AuNRs. 
Reproduced from ref. [233] 
 
As shown in Figure 4., prismatic-structured gold nanoparticles could have (111), (100) and (110) 
facets. The different growth rates of different faces and the different facets’ combination will 
form different shapes of nanocrystals. Short AuNRs are dominated by (110) and (100) facets, 
long AuNRs are dominated by (110) and (111) facets, and spherical gold nanoparticles with 
equivalent mass to the short rods are dominated by (100) and (111) facets with shapes of 
truncated octahedra, icosahedra and decahedra.  Furthermore, the unique (110) facets of 
AuNRs are expected to have particular surface properties.[233] 
Due to their exceptional radiative and nonradiative properties, the strong plasmonic 
properties of AuNRs and their tunability have prompted their application in the biomedical 
field (such as biosensing, biomedical imaging, gene and drug delivery, disease detection, 
diagnosis, and therapy).[9, 200, 234] To date, surface plasmon resonance (SPR) is the most 
appealing optical feature of metallic nanoparticles which consists of a collective oscillation of 
the conduction electrons.[235-237] In addition, the SPR in gold nanoparticles enhances locally 
the light electric field several orders of magnitude. For spherical gold nanoparticles, their SPRs 
lead to a  light absorption in the visible range of the spectrum (~ 525 nm) which overlaps with 
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some biological tissues and molecules such as hemoglobin in the bloodstream. Since the 
optical spectrum is directly correlated to the aspect ratio of the particles, the above-
mentioned limitation can be overcome by the synthesis of non-spherical AuNRs which 
possess two SPR bands. One associated with their cross-section, falls approximately in the 
same area of spherical nanoparticles, and the other with the excited longitudinal rod axis, 
shifts its perpendicular SPR to higher wavelengths (i.e.750-1200 nm) into the near-infrared 
region (NIR) where biological tissues and blood scarcely absorb.[238]  
Given that, standard UV–vis–NIR spectroscopy can easily monitor the formation of different 
aspect ratios AuNRs in solution. As the absorbance band changes with the refractive index of 
local material, AuNRs are considered excellent candidates for biological sensing and allow for 
extremely accurate sensing.[7] For example, the red-shift in the spectrum has been used to 
detect antigen by antibody functionalized AuNRs.[239, 240] 
AuNRs are electron dense and can be directly visualized by transmission electron microscopy 
(TEM) without the need of staining.[224, 241-244] The photothermal properties of AuNRs can be 
used to either directly kill cancer cells upon illumination or promote the release of 
therapeutic agents.[242, 245, 246] To prevent desorption and reduce toxicity , the surface of 
CTAB-coated AuNRs can be modified by replacing or covering with biocompatible compounds. 
For example, a thiolated DNA can be used to ‘displace’ the CTAB bilayer to form DNA-
modified AuNRs.[247] In addition, the CTAB bilayer can also be replaced first by a nonionic 
surfactant, and then exchanged with a cationic phospholipids. RNA can then further be 
associated to AuNRs through electrostatic complexation.[248]  
AuNRs can also be coated with a thermo-sensitive shell, for example based on poly (N-
isopropylacrylamide)[224, 249] that exhibits  lower critical solution temperature (LCST)[250-253] or 
upper critical solution temperature (UCST) behaviour[254, 255]. Irradiating these gold nanorods 
with NIR light can generate heat and induce a phase transition to releases the entrapped drug 
molecules. Meanwhile, the generated heat can also increase the efficacy of the released drug. 
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Carbon nanotubes (CNTs) are prone to aggregation. In this chapter, we report in stable CNTs 
suspensions obtained by either ultra-sonication or by the use of tannic acid as dispersant.  






 As a growth area in nanotechnology, high-aspect ratio nanomaterial carbon nanotubes 
(CNTs),[1-5] since their discovery in 1991,[6] have stimulated intense interest in their unique 
optical, electrical, magnetic anisotropy and biological properties which make them possess 
broad application prospects.[7-12] Depending on its number of graphene layers, CNT can be 
classified as single-wall carbon nanotubes (SW-CNTs)[13-17] and multi-wall carbon nanotubes 
(MW-CNTs).[6, 18, 19] They are only few nanometers wide, but in length can range from 
micrometers to millimeters.  Rated by elastic modulus, CNT are almost the strongest and 
stiffest materials, but by Young's modulus, they are soft in radial direction.[20-22] Both the 
length as well as aspect ratio play significant roles in their biological activity. Bare CNTs are 
hydrophobic and trend to agglomerate and deposit in aqueous medium due to high Van der 
Waals interaction forces along their length axis, leading to the formation of stacking 
bundles.[3, 23-27] Therefore, for biomedical applications, CNTs must be stably separated and 
then functionalized to afford water solubility and biocompatibility.[18] Moreover, an ideal 
functional CNT should possess minimal damage of the nanotube structure and contain 
available functional groups for further bio-conjugation.  
Among the methods that have been developed to disperse CNTs, there are two major 
functionalization strategies: covalent reactions[28-30] and non-covalent coating by amphiphilic 
molecules. [18, 26, 31-33] For example, with the addition of dispersants[34] such as sodium 
dodecyl sulfate (SDS), Triton X-100 or polyvinyl pyrrolidone (PVP), the CNTs suspension will 
aggregate and deposit if the excess coating molecules are removed. In addition, several 
dispersants have an ill-defined structures and exhibit neurotoxicity. Therefore, in this chapter 









Figure 1. Chemical scheme structure of tannic acid (TA).[35] 
 
RESULTS AND DISCUSSION 
Three different batches of carboxylic acid functionalized carbon nanotubes (CNTs-COOH) 
from different commercial sources were used: (1) multi-wall CNTs with a length of 1-10 µm 
(CNT-1), (2) single-wall CNTs with a diameter of 1.5nm and a length of 1-5µm, (CNT-2), (3) 
multi-wall CNT with a diameter of 9.5 nm and a length of 1.5µm (CNT-3). In dry state, we 
found by scanning electron microscopy (SEM) that all of these CNTs possess wider diameters 
than reported by the manufacturers (Figure 2.). Furthermore, attenuated total reflection 
fourier transform infrared spectroscopy (ATR-FTIR) in Figure 3.A showed that CNT-1, 
compared to graphite powder and the other two types of CNTs, had a distinct different 






Figure 2. Scanning electron microscope (SEM) images of three different batches of carboxylic acid 
functionalized carbon nanotubes (A) CNT-1, (B) CNT-2, and (C) CNT-3. The numbers (1,2) in the upper 
left corner refer to carbon nanotubes in powder (1) and drying-state of dispersed carbon nanotubes 
in tannic acid (2). Scale bars are shown under each image. 
 
 
Figure 3. ATR-FTIR spectra of (A) Graphite powder and three different batches of CNTs. The marked 
blue areas on the spectrum are the characteristic absorption peaks of –OH stretch (3400~3000nm) 
and -C=O stretch (1650~1740nm); (B) Carbon nanotubes in tannic acid (CNT-TA);  
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Next, we attempted to obtain stable CNT dispersions in deionized water or phosphate buffer 
saline (PBS) with or without the use of ultra-sonication. The role of ultra-sonication is to 
promote disentangling and exfoliation of the aggregated CNT bundles.[38-40] Without the help 
of ultra-sonication, CNT-1 could be well dispersed in both deionized water and PBS, whereas 
CNT-2 could only be well dispersed in deionized water and CNT-3 could not be dispersed in 
neither deionized water nor PBS (Figure 4.). This confirms our hypothesis that only CNT-1 
contained sufficient numbers of carboxylic acid groups to be well-dispersed with the help of 
ultra-sonication.  
As an alternative, we explored the use of a relative simple and low toxic natural surface-
active compound, i.e. tannic acid (TA; Figure 1.), to aid in the dispersion of CNTs without the 
using of ultra-sonication.[41] CNTs were mixed with TA, stirred for 2 or 3 days and dialyzed to 
remove the excess TA. This procedure allowed to obtain stable CNT suspensions from a batch 
of dry powder CNTs. SEM images (Figure 2.) of dried CNT-TA, showed that the CNTs were 
present as individual nanotubes due to the effect of tannic acid. ATR-FTIR (Figure 3.B) also 
illustrated that all of these CNT-TA batches contained TA. CNTs may be firstly coated with a 
monolayer of  tannic acid through interaction of the aromatic rings that could adsorb onto 
the surface carbon rings by π-π stacking,[18, 42] then further adsorb tannic acid by hydrogen 
bonds and other polar interactions.[41, 43-45] Therefore, we hypothesize that TA provides steric 
and/or electrostatic repulsion between the unfolded individual CNTs, hence preventing 






Figure 4. Photographs (left) and corresponding optical microscopy images (right) of dispersion of CNTs, 
(A) CNT-1, (B) CNT-2, and (C) CNT-3. The numbers (1,2 and 3) in the upper left corner refer to carbon 
nanotubes in tannic acid (1), in deionized water (2) and in phosphate buffer saline(PBS) (3). Scale bar 
represents 80µm. CNT-1 can be dispersed in a tannic acid (TA), deionized water and phosphate buffer 
saline(PBS); CNT-2 can be dispersed in a TA solution and deionized water but not in PBS buffer; CNT-3 
can only be dispersed in a TA solution, and precipitates in deionized water and PBS buffer.  
 
Once stable aqueous CNT suspensions were obtained, we subsequently aimed at 
investigating the interaction between these CNTs and model protein antigens (i.e. bovine 
serum albumin (BSA) and ovalbumin (OVA)).[48] BSA is a 66 kDa protein with an isoelectric 
point of 5.0-5.6 and OVA which is isolated from chicken egg white is a 43 kDa protein with an 
isoelectric point of 4.3. The concentration of CNT in suspensions was measured by UV-Vis 
spectrophotometry at 800nm[12, 18, 41, 49, 50] which showed good linearity in the 1 to 50µg/ml 
range and did not show interference with TA or BSA/OVA.  
First, we attempted to covalently conjugate BSA to blank carbon nanotubes (CNT) and tannic 
acid pretreated carbon nanotubes (CNT-TA) using carbodiimide chemistry reagent in 
different mediums.[13, 18, 51-55] Stable CNT suspensions were mixed with N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC.HCL) and sulfo-N-
hydroxysulfosuccinimide sodium salt (sulfo-NHS) in 2-(N-morpholino)ethanesulfonic acid 
(MES) buffer (pH 5.5). The excess EDC.HCL/sulfo-NHS/MES was subsequently removed by  
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centrifugation. After redispersion, the CNT and CNT-TA were reacted overnight with BSA in a 
1:1 weight ratio. Several washing and centrifugation cycles were performed to remove 
unbound proteins and concentrate the samples. Alternatively, we also mixed CNT with BSA 
without addition of carbodiimide coupling reagent. ATR-FTIR spectroscopy confirmed the 
presence (indicated by the blue area) of BSA in the respective CNT-BSA samples (Figure 5.A 
and Figure 5.B). 
 
 
Figure 5. ATR-FTIR spectra of (A) Bovine serum albumin (BSA); (B) BSA adsorbed onto CNT-TA. The 
marked blue area on the spectra originates from BSA. 
 
To allow for visualization by Fluorescence microscopy and confocal microscopy, fluorescently 
labeled BSA (FITC-BSA) was used. Figure 6. and Figure 7. showed a bright fluorescence 
emerging from the samples, whereas the bare CNTs under the same illumination and 
detection settings were found to be non-fluorescent. Figure 6. shows that FITC-BSA could 
spontaneous adsorb on CNT-3. The confocal microscopy images in Figure 7. also indicates 
that the FITC-BSA were capable to adsorb to these tannic acid pretreated CNTs in the 
absence of carbodiimide reagent. However, the use of carbodiimide reagent induces 
aggregation of CNTs. 
To assess the protein adsorption efficiency, the unbound FITC-BSA in the supernatant of the 




electrophoresis. Optical integration of Coomassie-stained gels was used to quantify the 
unbound protein content as demonstrated in Figure 8.A. CNT-1 exhibited a better coupling 
efficiency in the presence of carbodiimide reagent, whereas CNT-2 and CNT-3 displayed 
almost the same coupling ability in the presence or absence of carbodiimide reagent.  The 
same trends was also found by fluorescence spectroscopy, as shown in Figure 8.B. Moreover, 
the BSA absorbed CNT samples which were produced using carbodiimide reagent are 
aggregated.   
 
 
Figure 6. Fluorescence microscopy image of FITC-BSA adsorbed on CNT-3 that was pre-treated with 
ultra-sonication. The white appearances represent the bundled FITC-BSA. Scale bar represents 20µm. 
  




Figure 7. Confocal microscopy images of different CNT-TA suspensions, (A) CNT-1, (B) CNT-2, and (C) 
CNT-3 coupled to FITC-BSA in the presence (1) or absence (2) of carbodiimide reagent. The areas 
indicated by arrows and red circles show aggregations of CNTs by the use of carbodiimide reagent. 
Scale bars represent 20µm. 
 
 





To verify whether the high extent of protein adsorption to CNT in absence of carbodiimide 
reagent is unique for BSA, we also tested the adsorption of OVA. Figure 9. illustrated a similar 
tendency as observed for BSA. CNTs were previously treated with TA (CNT-TA) or ultra-
sonication (CNT-sonication). After reacting with AlexaFluor488 conjugated OVA (OVA-AF488) 
in a 1:1 weight ratio, CNT-1 in both situations (Figure 9.B, 1+ and 2+), CNT-2 and CNT-3 in TA 
(Figure 9.B, 3+ and 5+) were more stable than the other samples. Measuring the unbound 
protein fraction by SDS-PAGE and fluorescence spectroscopy (Figure 10.) gave further proof 
of the successful spontaneous adsorption of proteins on CNT-TA and CNT-sonication.  
 
 
Figure 9. (A) photographs of cuvettes containing CNTs in tannic acid and deionized water: (1) CNT-1-
TA; (2) CNT-1; (3) CNT-2-TA; (4) CNT-2; (5) CNT-3-TA; (6) CNT-3. Only CNT-3 in deionized water clearly 
deposited. (B) photographs of cuvettes containing corresponding CNTs with OVA (+): (1+) CNT-1-TA-
OVA; (2+)CNT-1-sonication-OVA; (3+)CNT-2-TA-OVA; (4+)CNT-2-sonication-OVA; (5+) CNT-3-TA-OVA; 
(6+) CNT-3-sonication-OVA.  




Figure 10. SDS-PAGE(A) and fluorescence spectroscopy(B) measurements of the unbound fraction of 
OVA. 
 
Subsequently, we investigated the in vitro uptake of CNT-BSA/OVA by the immortalized 
mouse dendritic cell line DC2.4.[56-58] Dendritic cells (DCs) were incubated overnight with the 
different CNT-BSA/OVA samples and measured by flow cytometry. Figure 11. & Figure 12. 
showed analogous trend to the aforementioned Fluorescence Spectrum and SDS-PAGE 
results. Although in presence of carbodiimide reagent, CNT and CNT-TA showed more 
efficient adsorption and cells uptake, the reagent disturbed the samples stability and caused 
aggregation. In addition, previously treated CNT with either ultra-sonication or tannic acid 
could spontaneous adsorb OVA. Ultra-sonication pretreatment could not only disperse CNTs, 
but also slice them and decrease their aspect ratio. That could be why the ultra-sonication 
treated CNT-OVA showed a little higher cells uptake behavior than the ones which were 















Figure 12. FACS analysis of DC2.4 cells which cultured with CNT-OVA, in the presence or absence of 
tannic acid. 
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Then, confocal microscopy was used to investigate whether these CNT-BSA/OVA were 
internalized by the DCs or merely bound with their surface. To be easily visualized, we used 
AlexaFluor555-labeled cholera toxin subunit B (CTB-AF555) to mark the cells membrane, 
while the cell nuclei were stained with Hoechst.[59] From both the staining cells images and 
the differential interference contrast(DIC) images(from Figure 13. to Figure 18.), it is clear 





Figure 13. Confocal microscopy images of DC2.4 cells incubated with different CNT-1-FITC-BSA 
samples. (A) CNT-1-TA coupled with FITC-BSA, (B) CNT-1-sonication coupled with FITC-BSA, and (C) 
CNT-1-TA coupled with FITC-BSA in the presence of carbodiimide reagent. The numbers (1,2) in 
the upper left corner refer to the staining cells images (1) and differential interference contrast (DIC) 
cells images (2). Scale bars represent 20 µm. (Note that, the staining cells images and DIC images are 
form the same samples but not from the same area or cells.) 




Figure 14. Confocal microscopy images of DC2.4 cells incubated with different CNT-2-FITC-BSA 
samples. (A) CNT-2-TA coupled with FITC-BSA, (B) CNT-2-sonication coupled with FITC-BSA, and (C) 
CNT-2-TA coupled with FITC-BSA in the presence of carbodiimide reagent. The numbers (1,2) in the 
upper left corner refer to the staining cells images (1) and differential interference contrast (DIC) cells 
images (2). Scale bars represent 20 µm. (Note that, the staining cells images and DIC images are form 





Figure 15. Confocal microscopy images of DC2.4 cells incubated with different CNT-3-FITC-BSA 
samples. (A) CNT-3-TA coupled with FITC-BSA, (B) CNT-3-sonication coupled with FITC-BSA, and (C) 
CNT-3-TA coupled with FITC-BSA in the presence of carbodiimide reagent. The numbers (1,2) in 
the upper left corner refer to the staining cells images (1) and differential interference contrast (DIC) 
cells images (2). Scale bars represent 20 µm. (Note that, the staining cells images and DIC images are 
form the same samples but not from the same area or cells.)  




Figure 16. Confocal microscopy images of DC2.4 cells incubated with different CNT-1-OVA-AF488 
samples. (A) CNT-1-TA coupled with OVA-AF488 and (B) CNT-1-sonication coupled with OVA-AF488. 
The numbers (1,2) in the upper left corner refer to the staining cells images (1) and differential 





Figure 17. Confocal microscopy images of DC2.4 cells incubated with different CNT-2-OVA-AF488 
samples. (A) CNT-2-TA coupled with OVA-AF488 and (B) CNT-2-sonication coupled with OVA-AF488. 
The numbers (1,2) in the upper left corner refer to the staining cells images (1) and differential 
interference contrast (DIC) cells images (2). Scale bars represent 20 µm.  
  




Figure 18. Confocal microscopy images of DC2.4 cells incubated with different CNT-3-OVA-AF488 
samples. (A) CNT-3-TA coupled with OVA-AF488 and (B) CNT-3-sonication coupled with OVA-AF488. 
The numbers (1,2) in the upper left corner refer to the staining cells images (1) and differential 






In summary, stable CNT suspensions could be obtained both by ultra-sonication and by 
treatment with TA, which provides steric and/or electrostatic repulsion between individual 
CNTs, thus preventing aggregation.[46, 47] However, in order to protect the nanotubes 
structure and aspect ratio, tannic acid pretreatment is more reliable than ultra-sonication 
and the use of carbodiimide reagent. We postulate that the bio-conjugation of CNTs and 
proteins will open new possibilities to utilize their properties for multifunctional subcellular 
targeting applications.  
  





Graphite and Multi-Wall CNT (CNT-1) were purchased from PlasmaChem GmbH, with the 
length 1-10µm. Single-Wall CNT (CNT-2) was purchased from NANO LAB, with the diameter 
1.5nm and length 1-5µm. Multi-Wall CNT (CNT-3) was purchased from Sigma-Aldrich, with 
the diameter 9.5nm and length 1.5µm . Cell culture media and additives, AlexaFluor488 
labeled ovalbumin (OVA-AF488), AlexaFluor555 labeled cholera toxin subunit B (CTB-AF555), 
Hoechst and propidium iodide were purchased from Life Technologies. 2-Mercaptoethanol, 
laemli sample buffer (4x), Coomassie blue stain (G-250) were purchased from Bio-rad. All 
other chemicals and solvents were purchased from Sigma- Aldrich. Deionized water was used 
for all experiments. 
 
Instrumentations 
Scanning electron microscopy (SEM) images were recorded on a quanta FEG FEI 200 
apparatus. Samples were deposited onto a silicon wafer and dried under a gentle nitrogen 
stream at room temperature. Prior to imaging, the samples were sputtered with a gold 
coating. 
Attenuated Total Reflection Fourier Transform Infrared Spectroscopy (ATR-FTIR). ATR-FTIR 
spectra were recorded on a Thermo Scientific Nicolet iS 5 FT-IR spectrometer. 
UV-VIS spectroscopy, UV-VIS spectra were acquired with a Shimadzu UV-1650PC 
spectrophotometer. CNTs suspension, Tannic acid solution and proteins solutions were 
placed in the cuvettes and spectral analysis was performed in a 200 to 1000nm range at 
room temperature. CNTs suspension, either Tannic acid nor protein, showed absorbance 
value at 800nm wavelength.  UV-VIS spectra was used to evaluate the final concentration of 
CNTs in the CNT~protein samples. The concentration of CNTs and the absorbance value 





Fluorescence microscopy was performed on a Leica DM2500P microscope equipped with a 
40x objective. 
Confocal laser scanning microscopy. 
Images were recorded on a Leica DMI6000B inverted microscope equipped with a 63× (1.4 
NA) oil immersion objective and connected to an Andor DSD2 confocal scanner. 
DC2.4 cells were plated a density of 5 000 per well in a small well (20µl * 25 000) and 
incubated overnight with samples. Cells were fixated with paraformaldehyde; cell nuclei were 
stained with Hoechst, and the cell membrane stained with CTB-AF555.  
Sodium Dodecyl Sulfate-polyacrylamide Gel Electrophoresis (SDS-PAGE).  
SDS-PAGE was performed with a 4-20 % polyacrylamide gradient gel using the Mini-PROTEAN 
Tetra Cell from Bio-Rad, at 180 V for 45 min. The unbound proteins samples which were 
contained in the supernatant of the first centrifugation cycle and the coupling samples were 
loaded onto polyacrylamide (PAGE) gels and applied an electric current. The samples were 
diluted with a 1:9 β-mercaptoethanol:laemli sample buffer solution (4×). After the run, 
visualization of the protein bands was obtained by incubated the gels into Coomassie blue 








The stability of CNTs’ suspension. 
Respectively dispersed our Carbon nanotubes in 0.5mg/ml original concentration of Tannic 
Acid solution(TA), stirred for 2 days and then dialyzed against deionized water 3 days by 
changing  the water every half-day to remove the excess Tannic Acid. Testing by the UV-Vis, 
Tannic Acid (TA) could help to disperse CNTs even with a very low final concentration in CNT-
TA suspension. These CNT-TA suspensions are stable at 4-7°C. And we also used ultra-sonic 
instrument to help these Carbon nanotubes dispersed in deionized water, the same CNTs 
final concentration as in CNT-TA suspension. 
Coupled CNTs with proteins. 
1 mg/mL of stock solution of BSA, FITC-BSA (when using fluorescence-based assays), OVA or 
OVA-AF488 (when using fluorescence-based assays) were prepared in phosphate buffer 
saline (PBS). 
Efficient Two-Step Coupling Protocol 
Firstly, parallel mixed different CNTs suspension with N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC.HCL) and N-Hydroxysulfosuccinimide sodium salt 
(sulfo-NHS) in 2-(N-morpholino)ethanesulfonic acid (MES) buffer (pH≈5.5) for 15min, then 
removed  the excess EDC.HCL/sulfo-NHS/MES by high speed centrifugation (20 min at 25.000 
G). Next, the re-dispersed CNTs suspensions were mixed with proteins in a 1:1 weight ratio 
and reacted overnight at 4-7°C. Several washing and high speed centrifugation (20 min at 
25.000 G) cycles were performed to remove unbound proteins and obtain the concentrated 
solution of CNT~adsorbed proteins.  
One-Step Coupling Protocol 
The one-step coupling protocol quitted the first step above, directly mixed different CNTs 




several washing and high speed centrifugation(20 min at 25.000 G) cycles to remove 
unbound proteins.  
In Vitro Cell Culture Experiments.  
DC2.4 Cell Line.  
The immortalized mouse dendritic cell line DC2.4 was a kind gift from Prof. Dr. Ken Rock 
(Dana-Farber Cancer Institute, Boston, MA, USA). Cell culturing was done in RPMI-glutamax, 
supplemented with 10% FBS, 1 mM sodium pyruvate, Glutamine, and antibiotics (50 units/Ml 
penicillin and 50 μg/mL streptomycin). Cells were incubated at 37 °C in a controlled, sterile 
environment of 95% relative humidity and 5% CO2. 
Cell Uptake Studies.  
DC2.4 cells were pulsed overnight with the CNT~protein samples, which containing FITC-BSA 
or OVA-AF488 and subsequently analyzed by FACS and Confocal Microscopy. Flow Cytometry 
was performed on a BD Accuri C6 flow cytometer. For Confocal Microscopy, cells were 
fixated with paraformaldehyde; cell nuclei were stained with Hoechst, and the cell 
membrane stained with CTB-AF555, both according to the supplier’s instructions. Images 
were recorded on a Leica DMI6000B inverted microscope equipped with a 63× (1.4 NA) oil 
immersion objective and connected to an Andor DSD2 Confocal Scanner. 
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Nanomaterials hold potential of altering the interaction between therapeutic molecules and 
target cells or tissues. High-aspect ratio nanomaterials in particular have been reported to 
possess unprecedented properties and are intensively investigated for their interaction with 
biological systems. Graphene oxide (GOx) is a water-soluble graphene derivative that 
combines high-aspect ratio dimension with functional groups that can be exploited for 
bioconjugation. Here, we demonstrate that GOx nanosheets can spontaneously adsorb 
proteins by a combination of interactions. This property is then explored for intracellular 
protein vaccine delivery, in view of the potential of GOx nanosheets to destabilize lipid 
membranes such as those of intracellular vesicles. Using a series of in vitro experiments, we 
show that GOx nanosheet adsorbed proteins are efficiently internalized by dendritic cells 
(DCs: the most potent class of antigen presenting cells of the immune system) and promote 
antigen crosspresentation to CD8 T cells. The latter is a hallmark in the induction of potent 
cellular antigen-specific immune responses against intracellular pathogens and cancer. 
 




Carbon-based nanomaterials offer a wide variety of potential applications, including those in 
the biomedical field. [1-4] Graphene oxide (GOx) is currently emerging as a multifunctional 
material, derived from graphene by oxidative treatment. [5-7] The planar structure, a water-
soluble graphene derivative with a 2D atomic layer composed of crumpled sheets of sp2− and 
sp3− hybridized carbon atoms, [8-11] is enriched with oxygen-containing groups such as 
epoxides, hydroxyls, and carboxylic acids that render GOx its hydrophilic properties.[12-15] 
Graphene oxide (GOx) is known for its particularly high-aspect ratio and surface area which is 
almost 10-fold of other nanomaterials.[16] High-aspect ratio materials are intriguing materials 
with respect to their interaction with living cells as they have been reported to pierce or 
destabilize lipid bilayer membranes.[17] This ability has been ascribed to carbon nanotubes,[18] 
and recently, Tu et al.[19] reported that GOx nanosheets, which is GOx with a size of a few 
hundreds of nanometers in the planar direction, can destabilize the membrane of bacteria. 
These features could render GOx an attractive nanocarrier for intracellular delivery of 
therapeutic molecules.[20, 21] 
In this paper, we aim at evaluating the potential of GOx nanosheets to enhance vaccine 
delivery efficiency. Nanomaterials hold excellent opportunities in vaccination,[22, 23] such as 
enhancing antigen uptake and presentation by dendritic cells (DCs) to T cells, and thereby 
could stimulate antigen-specific humoral and cellular immunity.[24, 25] Systems that are both 
of nanoparticulate nature and possess the ability to destabilize the membrane could be 
highly interesting. DCs are the sentinels of our immune system and continuously sample 
antigens that, in case these are accompanied by an appropriate “danger” signal, leads to 
activation of T cells and subsequently an antigen specific adaptive immune response.[26, 27] 
Soluble extracellular antigens, including administered vaccine antigens, are presented 
predominantly to CD4 T cells that play among others a role in conferring the antibody 
mediated humoral immune response.[28-30] However, to induce potent cellular immune 
responses, including the activation of cytotoxic T cells (CTLs) that can recognize and eradicate 
infected and malignant cells, the antigen needs to be presented to the CD8 T cells, which 
under normal conditions is only the case for intracellular cytoplasmatic antigens.[31, 32] Thus, 
strategies that could delivery protein antigens into the cytoplasm of dendritic cells are of 
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interest for vaccination against intracellular pathogens (e.g., HIV, malaria, tuberculosis)[33-36] 
and for tumor-associated antigens in view of anticancer vaccination.[37-39] Besides this, 
extracellular antigens that have a particle-shape morphology can also be presented by DCs to 
CD8 T cells, which is called cross-presentation.[25], [40-42] 
In view of these considerations, we put a particular focus in this paper on investigating the 
interaction between GOx nanosheets and proteins and the effect on protein uptake and 
presentation by DCs. Contrary to several other strategies reported in the literature to bind 
therapeutic molecules to GOx via a linker strategy, [24], [43-46] we strive in this paper to 
elucidate a facile method to formulate vaccine antigens with GOx without the requirement of 
additional reagents.  
PART II        
92 
 
RESULTS AND DISCUSSION 
GOx was prepared via a modified Hummers’ method involving oxidative treatment of 
graphite powder. [5-7] To produce nanosheets, the GOx suspension was extensively dialyzed 
until a neutral PH was reached and then ultrasonicated by a tipsonicator. To remove the 
fraction of nonexfoliated material, a centrifugation step at moderate force was applied and 
the final GOx nanosheet material was isolated in a dry state by lyophilization. This product 
could be readily resuspended in an aqueous medium to form a highly transparent solution, 
which was indicative of the presence of hydrophilic hydroxyl and carboxyl groups. 
Furthermore, the GOx nanosheets suspension remain colloidally stable for several days, 
indicating the lower micron to nanorange dimension of the material. Characterization by 
ATR-FTIR and AFM gave further proof of successful formation of GOx nanosheets (Figure 1.). 
The ATR-FTIR spectrum in Figure 1.A depicts the presence of functional groups introduced by 
the oxidative treatment. [15] Table 1. lists the annotated peaks. AFM (Figure 1.B) shows the 
formation of sheet-like structures with planar dimensions of a few hundreds of nanometers 
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Figure 1. (A) ATR-FTIR spectrum of native graphite and GOx obtained by oxidative treatment of 
graphite. (B1, B2) AFM images at different magnification of GOx nanosheets and corresponding height 
profile (B3) along the dotted line in panel B2. 
  




Table 1. List of functional groups in the ATR-FTIR spectrum of GOx nanosheets.  
wavenumber ( cm-1) peak assignment 
3400-2500, 1430, 950-900 -OH stretch 
1740-1650 -C=O stretch 
1300 -C-O 
1280-1230 epoxide ring stretch 
950-815 epoxide asymmetric ring deformation 
 
Next, we aimed at investigating the interaction between the GOx nanosheets and proteins. 
For this purpose, we used ovalbumin (OVA) which is albumin obtained from chicken egg 
white. It is a 43 kDa protein with an isoelectric point of 4.3, and it is widely used as model 
antigen in vaccine formulation research. Its amino acid composition is listed in Table 2.[48] 
where we have divided the amino acids into hydrophilic but neutral charged, acidic (i.e., 
negatively charged at neutral PH), basic (i.e., positively charged at neutrally PH), and 
hydrophobic. We also listed the full amino acid sequence of ovalbumin in Table 3.. Several 
other groups have covalently or nonspecifically modified GOx with linker chemistry to attach 
proteins. [24], [43-46] However, we reasoned that the presence of the remaining hydrophobic 
aromatic groups on the GOx surface could favor hydrophobically driven protein adsorption 
whereas the presence of epoxide moieties could allow covalent reaction with lysine units. 
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at neutral pH 
Basic 
positively charged 
at neutral pH 
Hydrophobic 
(non-polar) 
Glycine Gly G 19 Asparticacid Asp D 14 Arginine Arg R 15 Alanine Ala A 35 
Serine Ser S 38 Glutamate Gln Q 15 Lysine Lys K 20 Valine Val V 31 
Threonine Thr T 15     Histidine His H 7 Leucine Leu L 32 
Cystine Cys C 6           Isoleucine Ile I 25 
Tyrosine Tyr Y 10         Phenylalanine Phe F 20 
Asparagine Asn N 17         Trytophan Trp W 3 
Glutamine Glu E 33         Methionine Met M 17 
Proline Pro P 14             
 
  





















































































To roughly assess this possibility, both nonultrasonicated and ultrasonicated GOx were mixed 
with AlexaFluor488 conjugated OVA (OVA-AF488) in a 1:1 weight ratio, centrifuged at high 
speed (10 min at 10.000 G), and washed with deionized water to remove unbound OVA-
AF488 and imaged by confocal microscopy. The reason that we also used nonultrasonicated 
GOx is that its larger size affords better visualization of a full GOx flake, whereas GOx 
nanosheets have diffraction limited dimensions. The images in Figure 2. show a bright 
fluorescence emerging from both samples, whereas blank GOx images under the same 
illumination and detection settings were found to be nonfluorescent (data not shown). This 
provides a strong indication that OVA-AF488 is capable of spontaneously adsorbing onto GOx. 
Further proof of OVA adsorption on GOx nanosheets was obtained by ATR-FTIR spectroscopy. 
These experiments were performed using native, thus without fluorescent dye, OVA, and 
several washing and centrifugation steps were performed to remove unbound OVA. Figure 3. 
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depicted the ATR-FTIR spectrum of GOx~OVA in drying state after lyophilization. The 
characteristic bands at 1550 cm−1 (amide II band: C−N stretching vibraPon and N−H bending 
vibration) of OVA and 1750 cm−1 (−C=O stretch; left shoulder marked with green arrow in 
Figure 3.A) of GOx can be observed in the spectrum of GOx~OVA, indicating the presence of 
OVA on the GOx nanosheets. To investigate whether the secondary structure of OVA changes 
upon adsorption to GOx, we measured the circular dichroism (CD) spectrum for OVA mixed in 
different ratios to GOx. The reduction of the negative band at 222 nm that corresponds to a-
helix formation shown Figure 3.B indicates that the higher the ratio of GOx to OVA, the more 
OVA undergoes conformation changes and possibly denaturation. Of note is that, for 
enhancing T cell responses, the antigen needs to be processed into peptide fragments by 
dendritic cells (DCs) which does not depend on the structural integrity of the concerned 
protein. Liquid chromatography with tandem mass spectrometry/mass spectrometry 
detection of trypsin-digested OVA and GOx~OVA (2:1 ratio) was used to detect differences in 
the peptide composition after GOx adsorption. Figure 4. depicts a heat map of the abundancy 
of the peptide sequences that could be annotated by the mass spectrometer. Overall, a much 
lower total ion count was obtained from the GOx~OVA sample which indicates that GOx 
adsorption reduces to a certain extent the availability of the protein to be cleaved by trypsin 
(i.e., after lysine (K) and arginine (R) residues). Furthermore, significant differences in the 
abundancy of the different peptide sequences were observed. However, it remains elusive 













Figure 2. Confocal fluorescence microscopy images of (A) nonultrasonicated GOx and (B) 
ultrasonicated GOx nanosheets mixed with OVA-AF488. The main panel depicts a maximum intensity 
projection (MIP), with corresponding orthogonal XZ and YZ panels. 
 
 
Figure 3. (A) ATR-FTIR spectra of GOx, OVA, and GOx~OVA after removal of unbound OVA. 
Characteristic bands of GOx and OVA are highlighted in the respective spectra. (B) CD spectrum of 
OVA mixed with different ratios of GOx. The OVA concentration was kept constant at 1 mg/mL. 
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Next, we aimed to quantify the extent of GOx~OVA adsorption and to gather insight in 
whether the OVA is bound with the GOx via merely electrostatic interaction or also in part by 
covalent interaction. GOx and OVA were mixed in different weight ratios for 24 h, and 
subsequently, the GOx~OVA mixture and the supernatant after centrifugation was loaded 
onto polyacrylamide (PAGE) gels. By applying an electric current, GOx-bound OVA is 
separated from unbound OVA by electrophoresis. As the samples were first mixed with 
sodium dodecyl sulfate (SDS), we hypothesize that, in the case of the GOx~OVA mixture, 
most of the electrostatic and hydrophobic bonds will be broken and the fraction that will 
remain bound to the GOx will be predominantly covalently bound. Optical integration of 
Coomassie stained gels was used to quantify the free protein content, as illustrated in Figure 
4. As shown in Figure 5A., maximal GOx~OVA adsorption is reached at a 1:1 GOx:OVA ratio, as 
for this ratio onward no free OVA was detected in the supernatant anymore. However, at this 
and even higher GOx:OVA ratio, free OVA does become detected when the GOx~OVA 
mixture is loaded onto the SDS-PAGE. We attribute this to a fraction of weakly bound OVA 
that is released from the GOx nanosheets by the SDS and/or the electric current. We also 
assessed the effect of incubation time on protein adsorption and found (Figure 5.B) that 
incubation times shorter than 24 h led to a decrease in protein adsorption, although 
saturation emerged from 4 h onward.  
  





Figure 4. Schematic illustration of the procedure to measure OVA binding to GOx. (A) Sample 
preparation by mixing stock solution of GOx (orange sheets) and OVA (green dots), followed by 
sampling respectively the GOx~OVA mixture and the supernatant after centrifugation. (B) Sample 
analysis by SDS-PAGE. Strongly - presumably covalently - bound OVA will be retained in the wells, 
whereas the weakly - presumably non-covalently - bound OVA will be able to migrate in the gel due to 
the applied electric current. 
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Figure 5. Adsorption efficiency of (A) OVA and (B) lysozyme to GOx nanosheets as a function of (A1, B1) 
the GOx:proteins weight ratio and (A2, B2) mixing time. 
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To verify whether the high extent of protein adsorption to GOx nanosheets is unique for OVA 
but also valid for other proteins, we investigated the GOx adsorption behavior of lysozyme 
(LYS). LYS is a 14 kDa protein with an isoelectric point of 11.35. Taking into account the 
negative zeta-potential of −37 ± 1 mV of GOx, LYS is expected to strongly interact with GOx 
through electrostatic interaction. This is confirmed by the experimental data in Figure 5.B, 
which show that, contrary to OVA, LYS is almost fully (B1) and rapidly (B2) bound to GOx at a 
GOx:protein ratio of 1:2. Interestingly, when analyzing the GOx~LYS mixture by SDS-PAGE, a 
large fraction of the LYS appears to be released from the GOx nanosheets. This suggests that 
the presence of the SDS can efficiently break the electrostatic interactions between LYS and 
GOx. Such influence of SDS on electrostatically bound macromolecules is well-known and not 
unexpected. However, the resilience of the GOx~OVA complexes against high surfactant 
concentrations is attributed to the strong nature of the interaction between both 
components. The nature of these interactions, however, remains elusive. On the one hand, 
the 20 lysine residues in OVA give more likeliness for covalent interaction with epoxy groups 
on the GOx surface than the 6 (of which 3 are hidden within the 3D structure) lysines 
residues of LYS. On the other hand, the fact that 163 out of 386 amino acid residues of OVA 
are hydrophobic, whereas only 44 out of 129 for LYS, might also contribute to the likeliness of 
hydrophobic interactions to be the driving force for GOx~OVA complexation. 
In a subsequent series of experiments, we investigated the in vitro interaction between OVA-
AF488 loaded GOx nanosheets and dendritic cells (DCs). For this purpose, we used the 
immortalized mouse dendritic cell line DC2.4. DCs were incubated overnight with GOx~(OVA-
AF488) nanosheets and subsequently measured by flow cytometry. A dose-dependent 
cellular-association of OVA-AF488 is observed with a 1:1 ratio yielding the highest extent of 
cell association (Figure 6.). Confocal microscopy was used to investigate whether the 
GOx~(OVA-AF488) nanosheets were internalized by the DC or merely bound with their 
surface. To mark the cell membrane, we used AlexaFluor555-labeled cholera toxin subunit B 
(CTB-AF555) while cell nuclei were stained with Hoechst. The images in Figure 7. consist of a 
confocal section in combination with the orthogonal XZ and YZ planes and a maximum 
intensity projection (MIP), to provide a maximum of information. From the orthogonal planes, 
it is clear that the GOx~(OVA-AF488) nanosheets are located inside cells as well as stuck to 
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the cell membrane. Control experiments with soluble OVA yielded a punctuated pattern of 
green fluorescence inside the cells with no OVA being located on the cell membrane. 
 
 
Figure 6. Flow cytometry analysis (A) histograms exemplified for 0.08 μg/mL ova and (B) mean cell 
fluorescence of cellular association of GOx~(OVA-AF488) after overnight incubation with different 
doses and ratios of GOx:OVA. Note that, for the different GOx:OVA ratios, the concentration of OVA 
was kept constant in the respective experiments. 
 
  





Figure 7. Confocal microscopy images of DC incubated with (A) GOx~(OVA-AF488) nanosheets and (B) 
soluble OVA-AF488. Cell membrane was stained red fluorescent with cholera toxin subunit B, and cell 
nuclei were stained with Hoechst. The lefts panels represent a confocal section and the 
corresponding orthogonal planes; the right panels represent a maximum intensity projection (MIP). 
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Due to the diffraction limit of light, optical microscopy does not offer sufficient resolution to 
investigate in detail the intracellular behavior of the GOx~OVA nanosheets; transmission 
electron microscopy (TEM) was performed after osmium staining and embedding of the cells 
in epoxy resin followed by ultramicrotomy. The resulting TEM images are shown in Figure 8. 
for DCs pulsed with GOx~OVA, whereas Figure 9. also depicts TEM images of blank DCs, DCs 
pulsed with OVA, and DCs pulsed with GOx without OVA. The panels at higher magnification 
in Figure 8B−D highlight the different intracellular behavior of the nanosheets that is 
observed for both GOx and GOx~OVA. Nanosheets are found both inside and outside vesicles; 
the latter ones can be endosomes or phagosomes and are also found to be piercing through 
vesicle membranes. This gives proof that GOx is to a certain extent capable of destabilizing 
endo/lysosomal membranes and thus holds the potential to promote release of a GOx-
associated payload into the cytoplasm of the cell. It is also of note that even though the DCs 










Figure 8. Transmission electron microscopy (TEM) images of DCs pulsed with incubated with 
GOx~OVA. (A) Overview, (B) zoomed image depicting nanosheets inside a vesicle, (C) zoomed image 
depicting nanosheets outside vesicles, and (D) zoomed image depicting nanosheets piercing through 
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Figure 9. TEM images of blank DCs (A) and DCs pulsed with (B) OVA and (C) GOx. 
 
Finally, we aimed to investigate the immunobiological behavior of GOx in terms of enhancing 
antigen presentation by DCs to CD8 T cells. First, we investigated to which extent GOx 
induces toxicity and maturation of DCs. For this purpose, mouse bone marrow DCs were 
pulsed in vitro with different concentrations of GOx, followed by flow cytometry analysis of 
the cell viability (Figure 10.A) and upregulation (Figure 10.B) of the surface maturation 
markers MHCII and CD86. GOx by itself does not lead to significant DCs activation even up to 
toxic concentrations, which is in line with several other studies on nanoparticulate materials 
that without addition of specific immune-modulating compounds (such as, e.g., Toll-like 
receptor ligands) do not spontaneously activate DCs.[17] To investigate the effect of GOx on 
antigen presentation, mouse bone marrow derived DCs were pulsed with different 
concentrations of soluble OVA or GOx~OVA at different GOx:OVA ratios. Note that when 
preparing these samples, the OVA concentration was kept constant and the amount of GOx 
was varied. Subsequently, the DCs were cocultured with CFSE-labeled (CFSE: 
carboxyfluorescein succinimidyl ester) OT-I cells. The latter are CD8 T cells from transgenic 
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mice that carry the transgenic CD8 T cell receptor for the complex of MHCI with the OVA CD8 
peptide epitope SIINFEKL. Upon proliferation, the CD8 T cells divide their fluorescence over 
their daughter cells which allows measuring cell proliferation by flow cytometry analysis. Two 
ratios (i.e., 1:5 and 1:20) of DCs response, on both the T cells and cytokine level. Relative to 
soluble OVA, T cell proliferation is increased in the case of the GOx:OVA 1:1 and GOx:OVA 2:1 
formulations to a moderate extent whereas the GOx:OVA 1:2 formulation does not enhance 
T cell proliferation. This could suggest that the presence of an excess of GOx is favorable for 
enhancing antigen presentation rather than the presence of an excess of OVA. At the 
cytokine level (Figure 10.C) in the supernatant of the DC-T cell cocultures, very apparent 
trends can be observed, showing all three of the GOx~OVA formulations strongly promote 
DCs to secrete effector cytokines. These effects are not supported by large differences in 
proliferated T cells but are due to an enhanced capacity of the proliferating T cells to 
differentiate into effector T cells. The latter is an important aspect for future in vivo 
application of GOx-based vaccine formulations aiming for the induction of cytotoxic T cells, as 
has been observed in our previous work.[23] 
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Figure 10. (A1) In vitro cell toxicity of GOx measured by flow cytometry. (A2) Dendritic cell maturation, 
measured by flow cytometry. (B) OVA specific CD8 T cell proliferation. (C) Cytokine (C1: IFNγ; C2: IL13; 
C3: IL17) IFNγ secretion in cell culture medium measured by ELISA. The colored bars in B−C represent 
the level of T cell division, and respectively cytokine secretion, at that specific OVA dose. 
 
  




In conclusion, we have shown in this paper that GOx nanosheets can be used for adsorption 
of proteins, without the requirement of any additional linker strategy. When bound with GOx, 
ovalbumin, which was used as model protein antigen in this study, could still be internalized 
by dendritic cells. Importantly, we demonstrated in vivo in mice that GOx adsorption strongly 
enhances the antigen presentation in vitro. In view of these findings, GOx nanosheets could 
be attractive nanocarriers for vaccine formulation. GOx adsorption could, e.g., facilitate the 
formulation of vaccine antigens containing hydrophobic domains that would otherwise lead 
to macroscopic precipitation in pure aqueous medium. In addition, GOx could also be used 
for coformulation of molecular adjuvants[24] (e.g., the hydrophobic lipid derivatives MPLA and 
Pam-3-Cys) that can stimulate Toll-like receptors that are present on DCs and are potent 
stimulators of cellular immunity. These opportunities are currently being investigated in our 
laboratories. 
Besides that, it is important to highlight the current challenges regarding the use of GOx for 
biomedical applications. In addition to the uncertainty on the long-term fate of GOx and 
possible nanotoxicity issues, important work needs to be done in standardizing GOx 
production, especially in obtaining GOx with reproducible dimensions. However, owing to the 
unique features of GOx, in particular its planar ultrathin morphology and protein-adsorbing 
capacity, we do believe GOx merits the effort of being further investigated for intracellular 
delivery applications. 
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Graphite was purchased from PlasmaChem GmbH. Cell culture media and additives, 
AlexaFluor488 labeled ovalbumin (OVA-AF488), AlexaFluor555 labeled cholera toxin subunit 
B (CTB-AF555), Hoechst and propidium iodide  were purchased from Life Technologies. 2-
Mercaptoethanol, laemli sample buffer (4x), Coomassie blue stain (G-250) were purchased 
from Bio-rad. All other chemicals and solvents were purchased from Sigma- Aldrich. Purified 
Milli-Q grade water was used for all experiments. 
 
Instrumentations and Characterizations 
Attenuated Total Reflection Fourier Transform Infrared Spectroscopy (ATR-FTIR). ATR-FTIR 
spectra were recorded on a Thermo Scientific Nicolet IS 5 FT-IR spectrometer. 
Atomic Force Microscopy (AFM).  
AFM images were recorded on a Bruker Innova in dry state. The morphology of the graphene 
oxide nanosheets was investigated by tapping mode AFM. Air-dried films were deposited 
onto silicon wafers. Bruker Innova (a 100 μm scanner, a nominal spring constant of 3 N/m, 
and a frequency of 75 kHz) was used to obtained the samples’ images in tapping mode under 
ambient conditions in air. 
Transmission Electron Microscopy (TEM) 
Carbon-coated Cu grids (200-mesh) were used in all experiments. For TEM, a drop of GOx 
solution or GOx~OVA solution (at different GOx:OVA ratios) were allowed to air-dry onto a 
grid, and visualized using 80 keV TEM (Jeol 1010, Japan).  
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CD Spectrometry.  
CD spectra were recorded on a Jasco J-1100 CD spectrometer at an constant OVA 
concentration of 1 mg/mL (Figure 11.).  
Liquid Chromatography−Mass Spectrometry/Mass Spectrometry (LC-MS/MS).  
Extraction and digestion of OVA and GOx~OVA was performed as previously described.[49] 
Dried peptides were dissolved in 0.1% formic acid (FA) in water (buffer A), and half of the 
sample was injected on a reversed phase nanoHPLC column (Pepmap C18 column 15 cm, 
particle size 3 μm, 0.3 mm internal diameter by 150 mm; Dionex, Sunnyvale, CA, USA) using a 
linear gradient of 97:3 buffer A/buffer B to 20:80 buffer A/buffer B at 300 nL min−1 over 70 
min (buffer B: 80% ACN/0.1% FA). The different peptides were analyzed on a TripleTOF 5600 
(ABSciex, Framingham, MA, USA) in a data dependent mode. Data analysis was performed 
with Mascot Daemon (Matrix Science, London, UK) (peptide mass tolerance: 15 ppm; 
fragment mass tolerance: 0.3 Da; fixed modification: carbamidomethyl (C); variable 
modifications: carbamidomethyl (N-term), oxidation (M), deamidation (NQ)). 
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 Synthesis of GOx Nanosheets. 
GOx was prepared by a modified Hummers’ method by reacting graphite powder with the 
strong oxidizing agent potassium permanganate (KMnO4) in concentrated sulfuric acid.[5], [50-
53] A typical procedure was as follows: 110 mg of graphite powder and 55 mg of sodium 
nitrate were added to 6 mL of concentrated sulfuric acid in a 50 mL round-bottomed flask 
which was chilled in an ice-bath to maintain the reaction temperature below 10 °C. The 
reaction mixture was stirred overnight. The next day, 300 mg of KMnO4 was slowly added and 
the reaction mixture again was stirred overnight. During this period, the solution changed in 
color from black to dark green. Then, a second 300 mg portion of KMnO4 was also slowly 
added and again stirred overnight. Note that all these reaction steps were performed on an 
ice-bath. 
After that, the ice-bath was removed; the mixture was stirred for 2 h, allowed to reach room 
temperature, then placed in an oil-bath at 40 °C, and stirred overnight. During this period, 
the reaction mixture thickened and changed to a brownish-gray color. Next, 7 mL of 
deionized water was added dropwise under vigorous stirring and heated to 98 °C. Then, 7 mL 
of a 30% aqueous hydrogen peroxide solution was added, and the mixture turned to bright 
yellow. The oilbath was removed, and the reaction mixture was allowed to reach room 
temperature. 
After removal of the heating source and cooling to room temperature, the mixture was 
centrifuged at 15 000g for 30 min. The supernatant was decanted, and the pelletized 
material was washed 3 times with 50 mL of 10% HCL followed by repeated washing with 
deionized water until the PH reached a value of 3~4. After that, the mixture was put into 
dialysis bags and dialyzed against deionized water for several days with repeated refreshing 
of the water. To obtain GOx nanosheets, the GOx was dissolved in deionized water at a 1 
mg/mL concentration and tip-sonicated 4 times during 30 s at a power output of 40%. The 
small remaining fraction of large nonexfoliated GOx was then removed by centrifugation for 
10 min at 1000g. Finally, GOx was isolated in dry form by lyophilization (Figure 12.). 
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Figure 12. Photographs of GOx nanosheets before (left) and after (right) lyophilization. 
 
Protein Adsorption to GOx Nanosheets. 
A stock solution of OVA (and OVA-AF488 in a 50:1 ratio, when using fluorescence-based 
assays) or LYS was prepared at a total concentration of 2 mg/mL in phosphate buffer saline 
(PBS). A stock solution of GOx nanosheets in deionized water was also prepared at 2 mg/mL. 
Different OVA~GOx formulations were prepared by mixing GOx and OVA in different ratios as 
listed in Table 4., followed by overnight stirring.  
Protein adsorption to the GOx nanosheets was assessed by polyacrylamide gel 
electrophoresis (SDS-PAGE). Samples were stained by a MIX (4×) buffer (β-
mercaptoethanol/laemli sample buffer solution (4×) = 1:9), incubated for 5 min at 95 °C, and 
loaded on 10−15% precast polyacrylamide gels. Gels were run for 35 min at 180 V and then 
stained with Coomassie Blue (Bio-Safe Coomassie Stain, Bio-Rad). Optical integration was 
performed using the ImageJ software package. 
 
 




Table 4. Composition of the Respective GOx~OVA Formulations 

















1:2 0.5 1.0 3.5 5 0.4 
1:1 1.0 1.0 3.0 5 0.4 
2:1 2.0 1.0 2.0 5 0.4 
 
In Vitro Cell Culture Experiments.  
DC2.4 Cell Line. The immortalized mouse dendritic cell line DC2.4 was a kind gift from Prof. Dr. 
Ken Rock (Dana-Farber Cancer Institute, Boston, MA, USA). Cell culturing was done in RPMI-
glutamax, supplemented with 10% FBS, 1 mM sodium pyruvate, 10 mM HEPES buffer, 0.05 
mM 2- mercaptoethanol, MEM NEAM, and antibiotics (50 units/mL penicillin and 50 μg/mL 
streptomycin). Cells were incubated at 37 °C in a controlled, sterile environment of 95% 
relative humidity and 5% CO2. 
Cell Uptake Studies.  
DC2.4 cells were pulsed overnight with GOx~OVA nanosheets containing OVA-AF488 and 
subsequently analyzed by flow cytometry and confocal microscopy. Flow cytometry was 
performed on a BD Accuri C6 flow cytometer, and data were processed using the FlowJo 
software package. For confocal microscopy, cells were fixated with paraformaldehyde; cell 
nuclei were stained with Hoechst, and the cell membrane stained with CTB-AF555, both 
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according to the supplier’s instructions. Images were recorded on a Leica DMI6000B inverted 
microscope equipped with a 63× (1.4 NA) oil immersion objective and connected to an Andor 
DSD2 confocal scanner.[49] For transmission electron microscopy (TEM), cells were fixated in 
paraformaldehyde and glutaraldehyde and stained with osmium tetrachloride. Subsequently, 
the samples were embedded in epoxy matrix and ultramicrotomed. Images were recorded on 
a Jeol JEM 1010.  
CD8 T Cell Presentation Assay.  
Mouse bone marrow derived DCs were pulsed with different concentrations of soluble OVA 
and GOx~OVA formulations and subsequently cocultured with OVA specific transgenic CD8 T 
cells, according to previous protocols. [49] 
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Transiently thermoresponsive polymers that exhibit a soluble-insoluble switch in response to 
temperature, but gradually loose this property in response to a hydrolysis reaction have been 
widely reported for polymers with LCST behavior. However, transiently responsive polymers 
with UCST behavior in a relevant context are fairly unexplored. Here, we design such polymers 
by modification of poly(N-hydroxypropylmethacrylamide) with primary amide moieties that 
are capable to form strong hydrogen bonds, through a hydrolysable carbonate ester linkage. 
The resulting polymer reveals UCST behavior with a clearance temperature of 42° C in aqueous 
medium. Hydrolysis of the carbonate esters in the polymer side chains, over time at 
physiological conditions or accelerated by an external trigger such as NIR light in presence of 
gold nanorods, alleviates the UCST transition temperature, yielding fully soluble polymers at 
physiological conditions. 




Stimuli-responsive polymers, also called ‘smart polymers’, respond to chemical or physical 
changes by a change in solution behavior.[1-3] This unique property has fuelled the interest in 
these materials for a number of applications, including drug delivery, tissue engineering, 
separation, catalysis, sensors, etc…[4-9] Amongst the most intensively studied stimuli-
responsive polymers are those that exhibit lower critical solution temperature (LCST) 
behavior.[10, 11] Such polymers are soluble at low temperature due to extensive hydrogen 
bonding with the surrounding water molecules and subsequent hindered polymer-polymer 
interactions, but become insoluble above the LCST at which these hydrogen bonds are 
disrupted due to entropic reasons and polymer-polymer interactions are favored leading to 
phase separation.[12-15] 
Compared to LCST behavior, upper critical solution temperature (UCST) behavior involves 
polymers being water-insoluble below the UCST and soluble above the UCST.[16] Unlike their 
LCST counterparts, polymers that exhibit UCST behavior in fully aqueous environment – i.e. 
without the requirement of co-solvents – and which exhibit a globule-to-coil transformation 
close to the physiological temperature of 37 °C – could be attractive for biomedical applications, 
but are much less reported.[17] Generally, UCST polymers exhibit thermoresponsiveness on the 
basis of cohesive enthalpic interactions between polymer chains, such as hydrogen bonds and 
electrostatic interactions.[18, 19] 
The latter are commonly based on polybetaines or zwitterionic polymers that lose their UCST 
behavior in physiological media due to screening of the electrostatic charges. Therefore, most 
examples of UCST polymers operating within a physiologically relevant context are based on 
hydrogen bond formation between amide- or urea-based repeating units in the polymer 
backbone.[20, 21] Furthermore, a certain degree of hydrophobicity should be present along the 
polymer chain, too. In this regard, polymers containing acrylamide, acrylonitrile moieties and 
in particular poly(N-acryloyl glycinamide) have mostly been studied.[22-24] However, biomedical 
applications require polymeric materials to be degraded into water-soluble products that can 
be cleared from the body. Whereas gelatin is a good example of a degradable natural 
macromolecular UCST system,[25] degradable synthetic UCST systems that operate within a 
CHAPTER 3        A Synthetic Transiently  Thermoresponsive Homopolymer with UCST Behavior within A 
Physiologically Relevant Window 
129 
 
physiological window are extremely rare and only a few examples have been reported. Very 
recent work by Wurm et al. introduced an interesting class of phosphonate based copolymers 
that show UCST behavior in acid condition and degradability in alkaline condition.[26] However, 




Scheme 1. Transiently responsive UCST polymers. (A) Schematic representation of polymers that 
undergo a reversible temperature-induced coil to globule transition by UCST behavior and can 
irreversibly hydrolyze into fully water-soluble polymers. (B) Synthesis of HPMA-GA via CDI activation of 
HPMA. (C) Synthesis of poly(HPMA-GA) by RAFT polymerization. 
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In this study we choose poly(N-(2-hydroxypropyl) methacrylamide) (poly(HPMA)) as a 
polymeric scaffold owing to its biocompatible and non-immunogenic nature,[27, 28] and 
modified the hydroxyl-position with glycolamide through a degradable carbonate ester linkage. 
We reasoned that the resulting carbonate ester bond would contribute to both increased 
hydrophobicity and hydrogen bond formation, whereas the pending primary amide bond 
would be available for hydrogen bonding. Importantly, hydrolysis of the carbonate ester 
linkage should result in unmodified poly(HPMA) and loss of responsive behavior, i.e. water 
solubility (Scheme 1A.). The monomer synthesis is depicted in Scheme 1B, and is based on an 
utilization of our recently reported strategy for hydrophobic modification of HPMA.[29] In a first 
step, HPMA is activated with 1,1’-carbonyldiimidazole and, after purification, reacted with 
glycolamide. To avoid the formation of unwanted side-products by Michael-type addition 
between the methacrylamide moiety and the nucleophilic amine of the imidazole by-product, 
only twice excess of glycolamide was used. After careful purification by silica gel column 
chromatography, successful synthesis of HPMA-GA (note that GA refers to glycolamide) was 
evidenced by 1H, 13C, COSY, HSQC NMR and ESI mass spectroscopy (Figure 1.-5.). 
Next, we performed the polymerization of monomer 2 by reversible addition-fragmentation 
chain transfer (RAFT) polymerization targeting a degree of polymerization (DP) of 50 using 4-
cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid as chain transfer agent (CTA) 
and azobisisobutyronitrile (AIBN) as radical source (Scheme 1C). Triple precipitation of the 
resulting polymer into cold acetone, in which both CTAs as well as unreacted monomer of 
HPMA-GA are soluble but poly(HPMA-GA) is not, afforded the isolation of the pure polymer, 
as shown by 1H-NMR spectroscopy (Figure 6.) and size exclusion chromatography (SEC) (Figure 
7.). SEC also revealed a narrow molar mass distribution of 1.21 indicating good control over 
the polymerization reaction. Table 1. summarizes the properties of the obtained polymer. 
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Figure 1. 1H-NMR (400 MHz, DMSO-d6) of HPMA-GA. 
 
  





Figure 2. 13C-APT-NMR (100 MHz, DMSO-d6) of HPMA-GA. 
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Figure 3. 1H,1H-COSY-NMR (DMSO-d6) of HPMA-GA. 
  





Figure 4. 1H,13C-HSQC-NMR (DMSO-d6) of HPMA-GA. 
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To investigate the thermoresponsive properties of the polymer, aqueous solutions of the 
polymer were prepared at a concentration of 5 mg/mL. At first instance, we observed that 
heating to elevated temperatures was required to solubilize the polymer, whereas lowering of 
the temperature resulted in the solution to become hazy again – a phenomenon that could be 
repeatedly cycled as evidenced both by visual interrogation (Figure 8.A1), as well as by dynamic 
light scattering (DLS) (Figure 8.A2). These observations clearly evidence the UCST-behavior of 
poly(HPMA-GA) in water. DLS was used to study the thermal phase transition behavior of the 
polymer in more detail. To limit degradation of the carbonate ester linkages in the polymer 
backbone, these experiments were performed in a 50 mM acetate buffer at a PH of 5. The 
polymer solution was heated to 60°C and cooled to 25 °C at a cooling rate of 1K per 8 min to 
ensure that the UCST phase transition is thermodynamic and not a kinetic phenomenon. As 
evidenced by Figure 8.B, upon cooling of the polymer solution, a sharp transition from low to 
high light scattering intensity occurs at 42 °C. This indicates aggregate formation by the 
polymer in aqueous solutions when sur passing the UCST cloud point temperature. This is 
further evidenced when measuring the size of the aggregates, which are 820 nm below the 
UCST phase transition whereas soluble unimers (3.5 nm) are measured above the UCST phase 
transition (Figure 8.C). As a control, we also synthesized a HPMA homopolymer and a random 
copolymer of HPMA and HPMA-GA containing 15% of unmodified HPMA. Both polymers were 
found to be fully solubilize in water between 0 and 100 °C. Apparently, the presence of a minor 
fraction of hydrophilic HPMA moieties interferes with the molecular attractions of HPMA-GA 
and alleviates the UCST behavior, providing a good basis for the hypothesized transient 
solubility of poly(HPMA-GA). 
  




Figure 8. UCST behavior. (A1) Photographs of poly(HPMA-GA) solutions upon repeated heating and 
cooling and (A2) corresponding light scattering intensity measured by DLS. (B) Evolution of the light 
scattering intensity as function of temperature upon cooling of a 5 mg/mL poly(HPMA-GA) solution 
solubilized at 60°. (C) Aggregate size below and above the UCST measured by DLS. 
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Proof of hydrolytic instability of the poly(HPMA-GA) was gained by incubating both the 
monomer and the polymer in water at PH 7.4 and 37 °C, with intermittent sampling and 
subsequent 1H-NMR spectroscopic analysis to measure the hydrolysis kinetics (Figure 9.). As 
depicted in Figure 10.A, both HPMA-GA and the corresponding polymer undergo hydrolysis 
under the applied conditions. Interestingly, we observed that the polymer degrades faster than 
the monomer. Although not yet fully understood, it may be speculated that the presence of 
hydroxyl groups in the partially hydrolyzed polymer may auto-catalyze the hydrolysis of 
neighboring HPMA-GA units as we recently demonstrated for acetal containing transiently 
soluble LCST polymers.[30] To assess the effect of polymer hydrolysis on the UCST behavior, we 
solubilized the polymer in HEPES buffer at PH 7.4 by heating it above the UCST followed by 
cooling to 37 °C where it remained in the globular agglomerated state. This mixture was then 
monitored in time by DLS (Figure 10.B) and showed within a few hours a gradual transition of 
the polymer from the aggregated state to a solution of unimers, which we ascribe to gradual a 
gradual decrease of the UCST transition temperature upon hydrolysis of the polymer side 
chains until it becomes lower than 37°C leading to solubilization of the polymer. This is an 
interesting finding as it indicates that despite the relatively slow degradation of the polymer, a 
rather rapid phase transition takes place at physiological temperature and PH. This we ascribe 
to the strong influence of the presence of hydrolyzed HPMA residues on the UCST behavior of 
the resulting polymer. Altogether, these data suggest that when the temperature is maintained 
at the physiological values of 37 °C, the polymer will be able to undergo a globule-to-coil 
transition upon hydrolytic cleavage of the carbonate ester moieties in the polymer side chain. 
  









Figure 10. (A) Hydrolysis kinetics of HPMA-GA and poly(HPMA-GA) measured by appearance of the peak 
at 1 ppm in the 1H-NMR spectrum. (B) Evolution of the light scattering intensity and aggregate size as 
function of time upon incubation of poly(HPMA-GA) at 37 °C in HEPES buffer at PH 7.4.  
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As final part of this study, we explored the possibility to accelerate the polymer hydrolysis by 
means of an external trigger. In this regard near infrared (NIR) light is attractive as it has a high 
penetration depth in living tissue and is relatively harmless.[31, 32] Moreover, NIR light can be 
converted into thermal energy by gold nanorods (AuNRs) that show – owing to their high 
aspect ratio – two plasmonic peaks, including one in the NIR region. This prompted us to 
investigate whether poly(HPMA-GA) hydrolysis could be accelerated fostered by the heat 
generated by NIR irradiation of AuNRs, pushing the temperature of the medium beyond the 
UCST and hence induce hydration and faster hydrolysis of poly(HPMA-GA). AuNRs stabilized by 
CTAB were synthesized according to literature[33] and transferred to the aqueous phase by 
extensive dialysis. The AuNRs were characterized by transmission electron microscopy (TEM; 
Figure 11.A1) and UV-vis spectroscopy (Figure 11.A2), which confirmed the successful 
formation of rod-shaped nanoparticles with plasmon peaks at 510 nm and 806 nm. Irradiation 
of an aqueous AuNRs solution with an NIR laser (808nm, 380mW) resulted in heating of the 
solution up to 50°C which could be cycled back to ambient temperature upon alternated on/off 
switching of the NIR laser light (Figure 12.). Control experiments in which NIR laser light was 
applied in absence of AuNRs only yielded a minor heating of the solution (Figure 13.). We also 
confirmed that an aqueous solution of poly(HPMA-GA) could be heated upon NIR laser 
irradiation in presence of AuNRs (Figure 11.B). Subsequently, AuNR were mixed with 
poly(HPMA-GA) in aqueous medium buffered at a PH of 7.4, followed by NIR laser irradiation. 
In parallel, the experiment was repeated in absence of AuNRs. After 1, 2 and 3h of irradiation 
samples were collected and analyzed by 1H-NMR spectroscopy to determine the extent of 
polymer hydrolysis. These measurements (Figure 11.C) revealed a much faster hydrolysis of 
the polymer in presence of AuNRs and NIR laser irradiation, thereby demonstrating a proof-of-
concept that hydrolysis of poly(HPMA-GA) can be triggered by an externally applied physical 
source.  
  





Figure 11. (A1) TEM image of AuNR and (A2) corresponding UV-Vis spectrum. (B) Temperature of an 
aqueous poly(HPMA-GA) solution in absence (blue) or presence (red) of AuNRs in response to NIR 
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Figure 12. Change in temperature of an aqueous solution containing gold nanorods upon alternated 
ON/OFF switching of the laser light. 
 






















Figure 13. Change in temperature of aqueous solution with/without gold nanorods upon laser 
irradiation.  




In conclusion, we reported a transiently thermoresponsive UCST polymer that is operational 
within a physiologically relevant window in terms of temperature, ionic strength and PH. These 
polymers are obtained through modification of a well-established biocompatible polymer, i.e. 
poly(HPMA), through a degradable hydrolysis-sensitive carbonate linker. Carbonate hydrolysis 
alleviated the UCST behavior of the polymers, which could also be accelerated by addition of 
AuNRs and NIR laser irradiation. Taken together we believe that our findings represent a 
valuable addition to the armory of degradable responsive materials that form self-assembled 
structures at and below the physiological temperature and gradually go into solution upon 
spontaneous hydrolysis or by a noninvasive external stimulus. 
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Monomer of N-(2-Hydroxypropyl) methacrylamide (HPMA) was purchased from polysciences, 
the inhibitor of  hydrochinon-monomethylether was obtained from Fluka. All other chemicals 
were purchased from Sigma Aldrich of at least ACS grade, and used as received.  
 
Instrumentations 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 400MHz FT-NMR 
spectrometer using d6-DMSO as solvents. Chemical shifts (δ) are given in ppm relative to TMS. 
Electron spray ionization-mass spectroscopy (ESI-MS) was performed on a Waters LCT Premier 
XETM TOF mass spectrometer with a ZsprayTM source and ESI and modular LocksprayTM 
interface, coupled to a Waters alliance HPLC system. 
Size exclusion chromatography (SEC) was performed on a Shimadzu 20A system, equipped with 
a 20A ISO-pump and a 20A refractive index detector (RID). Measurements were executed in 
N,N-dimethylacetamide (DMAc) containing 50mM LiBr at 50°C with a flow rate of 0.700mL/min. 
Calibration of the 2 PL 5μm Mixed-D columns was done with polymethylmethacrylate (PMMA 
standards) obtained from PSS (Mainz). 
Ultraviolet-visible spectroscopy(UV-Vis) was performed on a Shimadzu UV-1650PC 
spectrophotometer. Gold nanorods were placed in plastic cuvettes, and spectral analysis was 








 Synthesis of HPMA-GA monomer 
The synthesis of monomer of HPMA-GA contains two steps. HPMA was firstly activated with 
CDI as reported previously.1 Briefly, 3.42g of 1,1’-carbonyldiimidazole (CDI) was dissolved in 
20mL of anhydrous DCM in a 100mL of round-bottom flask, and then 2.148g of HPMA was 
added into the obtained solution and kept reaction at room temperature under N2 atmosphere 
for 2.5h. Afterwards, the  organic phase was separated and washed with 50ml of water twice 
and dried over Na2SO4. Pure HPMA-CI was obtained as yellow oil by removing the solvents 
under reduced pressure. (yield 90%) 
The obtained activated monomer of HPMA-CI was mixed with excess of glycolamide (2 molar 
eqa.) and then dissolved in 20mL of anhydrous DMF under a nitrogen atmosphere. Prior to the 
reaction at 80°C for 24h under stirring, a small piece of inhibitor (hydroquinone monomethyl 
ether) was added into the solution to avoid auto-polymerization during this process.  The 
solvent was evaporated under reduced pressure and the pure monomer of HPMA-GA was 
obtained via passing through column with eluent of chloroform containing 3% of methanol 
(v/v).  (yield 85%) 
1H NMR (DMSO-d6, 400 MHz), δ[PPM]= 8.08 (t, J = 5.8 Hz, 1H, NH-C=O), 7.37 (d, J = 81.5 Hz, 
2H, NH2-C=O), 5.64 (dt, 1H, C=CH2), 5.33 (dt, J = 3.0, 1.5 Hz, 1H, C=CH2), 4.78 (pd, 1H, CH-
CH3), 4.42 (s, 2H, CH2C=O), 3.37 (m, 8H,CH-NH-), 3.21 (ddd, 1H, CH-NH-), 1.86 (dd, 3H, CH-
CH3), 1.17 (d, J = 20.1, 6.3 Hz, 3H, CH3-C=CH2). 
13C NMR (DMSO-d6, 400MHz), δ[PPM]= 168.41 (-CO-NH2); 167.93 (-CO-NH-); 153.85 (-COO-), 
139.72 (C=CH2); 119.29 (C=CH2); 73.66 (-CH-CH3); 64.62 (-CH2-CONH2); 42.91 (-CH2-NH-); 
18.60 (-CH-CH3); 17.34 (CH3-C=CH2). 
ESI-MS(acetonitrile): m/z=245.1122 [M+H]+; 267.0948 [M+Na]+; 283.0688 [M+K]+ 
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RAFT polymerization of HPMA-GA 
A Schlenk tubes with a stir bar was loaded with monomer of HPMA-GA, CTA and AIBN with 
molar ratio of 50:1:0.2. All compounds were dissolved in anhydrous DMAc with final monomer 
concentration of 1M. Then the obtained solution was degassed via 4 cycles of freeze-pump-
thaw, and then put into pre-heated oil bath at 70°C for 70h under vacuum. A 1H-NMR sample 
of the reaction mixture dissolved in DMSO-d6 was analyzed showing 75% monomer conversion. 
The resulting polymer was isolated by precipitation in acetone and centrifugation. After re-
dissolving in few mL of DMAc, this process was repeated three times. The precipitated polymer 
was dried for 12h at room temperature under vacuum, affording poly(HPMA-GA). 
UCST behavior of poly(HPMA-GA)  
The UCST behavior of poly(HPMA-GA) in aqueous solution was investigated by DLS. Briefly, the 
polymer was dissolved in preheated 50mM acetated buffer with a PH of 5 at a concentration 
of 5mg/mL. The sample was then cooled from 60 to 25°C using a 1 °C interval. During cooling, 
the size and scattering intensity were measured. The cloud point of the polymer was estimated 
as the onset on the X-axis obtained by extrapolation of the scattering intensity-temperature 
curve to intensity baseline.  
Hydrolysis of HPMA-GA  
1) hydrolysis of HPMA-GA monomer 
100mg of monomers were first dissolved in 0.5mL DMSO, followed by being added dropwise 
into 10mL of PBS at 37°C under stirring. At different time intervals (1h, 2h, 4h, 8h, 12h, 24h, 
96h,192h, 364h, 720h), 1mL of solution was taken out to be freeze-dried and then re-dissolved 
in DMSO-d6 for 1H-NMR measurement. 
2) hydrolysis of HPMA-GA polymer 
100mg of polymers, synthesized by RAFT polymerization as reported earlier, were first 
dissolved in 0.5mL DMSO, followed by being added dropwise into 10mL of PBS at 37°C under 
stirring. At different time intervals (1h, 2h, 4h, 8h, 12h, 24h, 96h,192h, 364h, 720h), 1mL of 
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solution was taken out to be freeze-dried and then re-dissolved in DMSO-d6 for 1H-NMR 
measurement. 
Hydrolysis effect on UCST behavior 
To assess the effect of polymer hydrolysis on the UCST behavior of the polymer, the polymer 
was dissolved in 25mM Heppes buffer with pH7.4 at a concentration of 5mg/mL by heating it 
above the UCST. Followed by cooling to 37°C, the size and scattering intensity as a function of 
time was then monitored by DLS.  
Synthesis of CTAB@AuNR 
The gold nanorods (AuNRs) were synthesized as described before with a little modification.2 
All glass vials were first cleaned by aqua regia  (3:1 of HNO3: HCl) and then rinsed with MilliQ 
water several times prior to the synthesis. Firstly, 5mL of 1mM HAuCl4 was mixed with 5mL of 
0.2M CTAB aqueous solution, and the color turned orange immediately. 290µl of 4.0mM 
AgNO3 was added into the solution above and vortexed for 5 seconds, and then 8µl of 37% HCl 
was added and gently shaken for 5 seconds. 70µl of 78.8mM ascorbic acid aqueous solution 
was added and the solution became colorless during 10s under gently shaken. Afterwards,15µl 
of fresh prepared ice-cold 0.01M NaBH4 aqueous solution was added into the colorless solution 
without shaking and put into water bath at 30°C for 6h, allowing for the growth of gold 
nanorods. Excess of CTAB in AuNRs solution was removed by 3 cycles of centrifugation at 
15000rpm for 20min at room temperature, and the precipitated AuNRs were dispersed in 
MilliQ water and stored in fridge. The resulting gold nanorods had dimension of 27×5 nm, with 
an aspect ratio of ~5, and longitudinal plasmon absorption at 806nm.  
Near infrared radiation(NIR)- induced Hydrolysis of poly(HPMA-GA) 
120mg of poly(HPMA-GA) was dissolved in 0.6mL DMSO, and then 50uL of polymer DMSO 
solution was added into 1mL of PBS solution containing 66.7uL of gold nanorods stock solution 
with a  concentration of 1mg/mL, followed by NIR irradiation (wavelength: 808nm, power: 
380mW) for 1h, 2h, and 3h, respectively. The change in temperature of the solution during NIR 
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irradiation was monitored. Afterwards, samples were freeze-dried and then re-dissolved in 
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Broader International Context, 
Relevance and  
Future Perspectives 
 
High-aspect ratio nanomaterials, owing to their unique electrical, optical and mechanical 
properties, especially their large surface areas, are intensively investigated for their 
interaction with biological systems.[1-4] Such anisotropic nanomaterials also hold 
opportunities in an immune-oncological context, owing to their relatively efficient 
internalization by cancer cells, which often exhibit increased phagocytotic behaviour, and 
antigen presenting cells.[5-8]  
However, an important challenge that arises when envisioning the use of such nanomaterials 
as drug carriers is to keep the formulation simple and scalable, involving a minimum of steps 
and to avoid reactive chemistry and toxic organic solvents.[9, 10] Additionally, clinical 
applications of high-aspect ratio nanomaterials are still in their infancy. Therefore, there is 
still much work to be done. 
Different structures, sizes, charges, shapes and surface chemistry determine different 
biological activity of nanomaterials.[11] As a growth area in nanotechnology, high-aspect ratio 
carbon nanotubes (CNTs),[6, 12-15] since the first discovery in 1991,[16] have stimulated intense 
interest in their unique optical, electrical, magnetic anisotropy and biological properties 
which has offered exciting opportunities for a variety of applications. [17-22]  
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Bare CNTs are hydrophobic and trend to self-associate into micro-scale aggregates. Therefore, 
the goal of Chapter 1, was to devise a simple strategy for the debundling and bio-
functionalization of CNT. For this purpose, three different batches of carboxylic acid 
functionalized carbon nanotubes (CNTs-COOH) from different commercial sources were 
tested.  
There are two distinct approaches that have been reported in the literatures for dispersing 
carbon nanotubes: mechanical methods (ultra-sonication, refluxing and high shear mixing)[23-
26] and processing methods to alter the surface energy, i.e. physically (non-covalent 
adsorption)[23, 24, 26] and/or chemically (covalent treatment).[25, 27-29] However, mechanical 
dispersion methods could not only separate nanotubes from each other, but also slice them 
and  decrease their aspect ratio.[23, 24, 30, 31]  
Chemical treatments, aiming at surface functionalization of CNTs side wall or opening their 
ends to enhance the chemical compatibility and reduce their tendency to agglomerate.[23, 25, 
28, 32-36] Nanotube–polymer composite is a good example,[37-39] such as SWCNT–polystyrene 
composites made by latex technology,[40] SWCNT–polyimide[41, 42] and poly-
(phenyleneethynylene) functionalized SWCNT–polystyrene composites[43]. However, 
chemical methods often introduce structural defects (reduction in average length and 
sidewall disordering). Alternatively, non-covalent approaches by wrapping of surfactants or 
polymers is particularly attractive, without disturbing the π-π structure of CNT and preserving 
their intrinsic properties.[44-47] Hereto, we have chosen a mild mechanical method based on 
ultra-sonication and non-covalent adsorption of tannic acid to unbundle CNT and, at the 
same time, to minimize the tubes shortening. The obtained dispersions are stable, without 
precipitation, upon prolonged their storage(months) under ambient conditions. 
Thanks to the vehicle structure of CNT, they have been proven to possess the ability to pierce 
the cytoplasmic membrane and nuclear membrane of cells.[48-53] Moreover, partly due to the 
EPR effect,  CNT appears much more accumulation in cancerous tumour tissue than in 
normal tissues.[48] Given that, owing to their high surface area and rich electronic 
polyaromatic structure, CNTs are able to conjugate with a wide variety of ligands (drugs, 
proteins, peptides, polysaccharides, enzymes, etc.).[54-58] Bio-conjugation is a future tendency 
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on cancer treatment research. For example,  SWNTs can be efficiently burdened with 
aromatic chemotherapy drug doxorubicin (DOX) via supramolecular π-π stacking.[57, 58] 
Meanwhile, the antibody Herceptin that is specifically over-expressed on a wide range of 
human breast cancer cells,[59] was  first thiolated by Traut’s reagent to produce active thiol 
groups for bio-conjugation with CNTs.[60, 61] Also for siRNA, CNTs are first reacted with a 
bifunctional linker, Sulfosuccinimidyl 6-(3’-[2-pyridyldithio]-propionamido) hexanoate (Sulfo-
LC-SPDP) and then bio-conjugated with thiolated siRNA via a cleavable disulfide bond.[62-64] 
Additionally, the most common strategy for the bio-conjugation is still the protocol with the 
help of EDC/Sulfo-NHS,[58, 65-70] which could destroy the stability of CNT dispersions. 
Therefore, in this thesis, we directly used the obtained water-soluble CNT~TA to couple with 
model proteins (BSA and OVA) in absence of other linker strategies. 
Confocal microscopy showed that protein-adsorbed CNT were efficiently internalized by 
dendritic cells. This is in accordance to earlier reports by the Kotov’s group,[71] that CNTs 
showed fast and deep permeation into the tissue, which is often difficult to realize with 
anticancer agents. For the treatment of cancer and other diseases, understanding the 
transport of carbon nanotubes (CNTs) as nanocarriers within tissues and cells is essential for 
biomedical imaging and drug delivery.[72-74] Further controlling the subcellular delivery of 
CNTs is also important for the realization of safe and effective cellular therapies.[75-77] We 
postulate that the bio-conjugation of CNTs and proteins will open new possibilities to utilize 
their properties for multifunctional subcellular targeting applications. Xing-Jie Liang and co-
workers provided evidence that SWCNTs may be useful for the treatment of 
methamphetamine addiction.[21] Therefore, these nanotubes are expected to be further 
developed as a new approach for the treatment of drug abuse and addiction. Additionally, 
their environmental behaviour and ecological risk (toxicological studies) are also attracting 
great attentions.[78, 79] In future, more studies are required to address these issues. 
Besides these, due to the magnetic anisotropy, carbon nanotubes (CNTs) could be used as an 
improved contrast agent relative to other spherical nanomaterials for magnetic resonance 
imaging (MRI) applications [80, 81] and also hold promise for the construction of high-efficiency 
solar cells.[82, 83]  
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Graphene oxide (GOx) stands out among the graphene derivatives[84] and is generating great 
interest, not only from the point of view of academic curiosity, but also considering its 
potential applications in a wide range of areas.[85-87] This water-soluble material is highly 
transparent and combines high-aspect ratio dimension with hydrophilic functional groups 
such as epoxide, hydroxyl and carboxyl groups.[88-91] Due to these oxygen functional groups 
which are linked to the hexagonal carbon structure, the chemical versatility of GOx makes it 
relatively easy to be further modified with organic molecules or biological structures.[92, 93] In 
addition, GOx could also be reduced into graphene typically by chemical or thermal methods 
as intermediate species.[92, 93] Contrary to several other linker strategies which were reported 
to bind therapeutic molecules to GOx with the help of Tannic Acid,[94-97] gold or silver 
nanoparticles, etc.[96, 98-103], in Chapter 2 of this thesis a facile method was elucidated to 
formulate vaccine antigens with GOx without the requirement of additional reagents. 
Confirmed by different techniques, we observed that GOx can be coupled to proteins 
spontaneously without the need for introducing specific linker strategies. The nature of these 
interactions, however, remains elusive. Owing to the random distribution of the oxygen-
containing functional groups, the precise atomic structure of GOx is still uncertain and yet 
remains to be fully elucidated.  
It was observed that, due to the high aspect ratio and surface area of GOx, which has been 
reported to pierce or destabilize lipid bilayer membranes of living cells and bacteria,[5, 104, 105] 
GOx nanosheet with adsorbed proteins could strongly promote DCs to secrete effector 
cytokines and antigen cross-presentation to CD8 T cells.[104, 105] The later one is a hallmark in 
the induction of potent cellular antigen-specific immune responses against intracellular 
pathogens(e.g. HIV, malaria, tuberculosis) and cancer. These features could render GOx an 
attractive nanocarrier for intracellular delivery of therapeutic molecules and enhance vaccine 
delivery efficiency.  
However, it is also important to highlight the current challenges regarding the use of GOx for 
biomedical applications. The large scale production of standardizing GOx,[106, 107] especially 
with reproducible dimensions, are still far from the criteria that are required for industry or 
commercialization with the satisfactory precision and reproducibility.[108] Furthermore, one 
hurdle preventing the widespread use of GOx is the lack of miscibility of the nanoplatelets 
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with functional polymer matrixes. Besides these, the uncertainty on the long-term fate of 
GOx and possible nanotoxicity issues are also restricting their potential applications. Bearing 
all of the aforementioned unique features and challenges of GOx in mind, in particular its 
planar ultra-thin morphology and protein-binding capacity, we do believe GOx merits the 
effort of being further investigated for intracellular delivery applications. 
To date, cancer is still a leading cause of dead. Although a large number of drugs and 
methods to relieve the negative impacts by cancer have been developed, off-target side 
effects are continuing disturbing the patients’ quality of life.[109] So there is a clear need for 
more efficient strategies for the delivery of anti-cancer drugs which should only be 
internalized by cancer cells and would not affect healthy cells and tissues.[110, 111] This has 
prompted the development of stimuli-responsive polymer-based delivery systems that can 
respond to a specific trigger and release a drug payload, preferably inside a cancer cell. 
Among the stimuli-responsive polymers which are also called ‘smart polymers’[112-114] and 
responding to chemical or physical changes by the change in solution behaviour, transiently 
thermoresponsive polymers exhibit a soluble-insoluble switch in response to temperature,[115, 
116] but gradually loose this property in response to a hydrolysis reaction in the polymer 
backbone or side-chain, are attractive biomaterials for the drug delivery.  
Compared to a rather common phenomenon lower critical solution temperature (LCST) 
behaviour which means the polymers are soluble at low temperature but become insoluble 
above LCST,[117-121] upper critical solution temperature (UCST)[122] behaviour is the inverse of 
LCST behaviour. This means that a polymer is insoluble below a critical temperature but 
becomes soluble above this temperature, which is a relative rare phenomenon in aqueous 
media. This unique property has fuelled the interest in these materials for a number of 
applications, including drug delivery, tissue engineering, separation, catalysis, bio-sensing 
etc..[123-125] For example, gelatine is a degradable natural macromolecular UCST system,[126, 127] 
whereas degradable synthetic UCST systems that operate within a physiological window are 
extremely rare and limited to only a few examples. Very recent work by the Wurm group 
introduced an interesting class of phosphonate based copolymers which show UCST behavior 
in acid condition and degradability in alkaline condition.[128] However, due to the presence of 
ionisable groups these polymers did not exhibit UCST behaviour at physiological pH. 
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Therefore, in Chapter 3, we chose poly(N-(2-hydroxypropyl)methacrylamide), owing to the 
biocompatible and non-immunogenic nature, as a polymeric scaffold to obtain a  
biocompatible and biodegradable transiently thermoresponsive homo-polymer,[129, 130] 
Poly(HPMA–glycolamide), through a degradable hydrolysis-sensitive carbonate ester 
linkage.[131] Most examples of UCST polymers operating within a physiologically relevant 
context are based on hydrogen bond formation between amide- or urea-based repeating 
units in the polymer backbone. Poly(HPMA–glycolamide) possesses upper critical solution 
temperature (UCST) behavior at 42°C in aqueous medium. Additionally, at a physiological pH, 
this polymer could undergo a globule-to-coil transition and gradually lose its UCST behaviour 
upon the hydrolytic cleavage of the carbonate ester moieties in the polymer backbone.  
AuNRs, owing to their high-aspect ratio, have two plasmonic peaks at 510 nm and 806 nm 
and  can convert the irradiation NIR laser into thermal energy. Near infrared (NIR) light is 
attractive as it has a high penetration depth in living tissue and is relatively harmless[132, 133]. 
AuNRs with poly(HPMA-glycolamide) in aqueous subjected to NIR laser irradiation could be 
heated and work as an external trigger to accelerate the hydrolysis of poly(HPMA-
glycolamide). Equally important, irradiating these AuNRs with NIR light could generate heat 
and induce a phase transition to release the payload drug.[134, 135] Meanwhile, the generated 
heat can also increase the efficacy of drug molecules which have been localized to the certain 
area.[122, 124] 
It is certainly interesting to investigate in future endeavours the influence of anisotropy on 
the interactive properties of polymer-functionalized gold nanoparticles. However, it is worth 
to point out that each material has its own disadvantages (such as issues of dosage, toxicity 
and potential risks to human health and the environment). Furthermore, our investigation on 
the biological interaction between polymer-functionalized gold nanoparticles and living cells 
were limited to in vitro settings. The behaviour of these systems in vivo still needs to be 
explored and recent findings by the Parak group have suggested that the presence of 
enzymes can strongly alter the in vivo fate of polymer coated gold nanoparticles.[136]  
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Summary and  
General Conclusions 
 
This PhD dissertation explores potential biomedical applications of three different high-
aspect ratio nanomaterials in three chapters, which are summarized below.  
In Part I, a general introduction was provided to discuss the importance of materials science 
to our lives, especially regarding biomedical applications of high-aspect ratio nanomaterials 
such as carbon-derived multi-dimensional nanomaterials (zero-dimensional fullerene; one-
dimensional carbon nanotubes; two-dimensional graphene and graphene oxide nanosheets; 
three-dimensional graphite and diamond) and polymer-functionalized inorganic metal 
nanoparticles, i.e. gold-nanorods. 
In Part II and Part III, three experimental chapters were presented. Structure, size, charge, 
shape and surface chemistry play key roles with respect to the bioactivity of nanomaterials.  
Carbon nanotubes (CNTs) are hydrophobic and trend to aggregate in aqueous media due to 
the high Van der Waals interaction forces along their length axis. Hence, for biomedical 
applications, CNTs must be functionalized to afford water solubility and biocompatibility. 
Furthermore, an ideal functional CNT should exhibit minimal damage of nanotube structure 
and have availability of functional groups for further bio-conjugation. 
In Chapter 1, three different batches of carboxylic acid functionalized carbon nanotubes from 
different commercial sources were chosen, with different diameters, length and number of 
walls. Ultra-sonication and tannic acid were used to render these CNTs dispersible in water. It 
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was found that tannic acid could efficiently stabilize CNTs, even in absence of sonication. 
ATR-FTIR proved that all of these CNTs had been covered by tannic acid. 
Next, we investigated the protein coupling ability of these CNT-TA and found that all of them 
could successfully spontaneous adsorb the model proteins, i.e. BSA and OVA.  
The aim of Chapter 2 was to investigate the potential of graphene oxide (GOx) nanosheets for 
intracellular delivery of proteins. GOx nanosheets were prepared by a modified Hummers’ 
methods, and ATR-FTIR and AFM gave further proof of successful formation of 
monomolecular layered GOx nanosheets which were highly transparent and combined high-
aspect ratio dimension (sheet-like structures) with hydrophilic functional groups such as 
epoxide, hydroxyl and carboxylic acids. 
Contrary to several other linker strategies which were reported to bind therapeutic 
molecules to GOx, we aimed in Chapter 2 to elucidate a facile method to formulate vaccine 
antigens with GOx without the requirement of additional reagents. Confirmed by ATR-FTIR, 
SDS-PAGE and fluorescence spectroscopy and microscopy, we observed that GOx nanosheets 
can be spontaneous coupled to proteins which were used as model protein antigens without 
the need for introducing specific linker strategies. When bound to GOx, we further 
investigated the interaction between protein (i.e. OVA) loaded GOx and dendritic cells in 
vitro. The obtained GOx~OVA could still be internalized by dendritic cells and promote 
antigen cross-presentation to CD8 T cells. The latter is a hallmark in the induction of potent 
cellular antigen-specific immune responses against intracellular pathogens and cancer. 
Apart from the carbon-derived multi-dimensional nanomaterials, in Chapter 3, we also 
elaborated on another type of high-aspect ratio nanomaterials, i.e. gold nanorods (AuNRs) as 
an external trigger in combination with a polymer that exhibits upper critical solution 
temperature (UCST) behaviour. In particular we were interested in developing a transiently 
thermoresponsive UCST polymer. Such polymer should exhibit a soluble-insoluble switch in 
response to temperature, but gradually loose this property in response to a hydrolysis 
reaction in the polymer backbone or side-chain. In Chapter 3, we developed a fully synthetic 
approach to obtain a biodegradable transiently thermoresponsive homo-polymer, i.e. 
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poly(HPMA–glycolamide), which possesses upper critical solution temperature (UCST) 
behaviour in aqueous medium.  
Hereto we have chosen a well-established biocompatible polymer poly(N-(2-
hydroxypropyl)methacrylamide) as a polymeric scaffold and modified the hydroxyl-position 
with glycolamide through a degradable carbonate ester linkage, thereby yielding HPMA-GA. 
Polymerization of HPMA-GA by reversible addition-fragmentation chain transfer (RAFT) 
polymerization resulted in a polymer with an UCST at 42° C, and that could be repeatedly 
cycled when alternatingly raising/lowering the temperature. Furthermore, at a physiological 
pH, when the temperature is maintained at the physiological values of 37 °C, the polymer 
undergoes a globule-to-coil transition upon hydrolytic cleavage of the carbonate ester 
moieties in the polymer backbone. 
AuNRs stabilized by CTAB were prepared via a one-step seedless method and transferred to 
the aqueous phase by extensive dialysis. Owing to their high-aspect ratio, these AuNRs have 
two plasmonic peaks, i.e. at 510 nm and 806 nm. These AuNRs can convert NIR light into 
thermal energy. Hence, mixed AuNRs with poly(HPMA-GA) in aqueous medium buffered at a 
pH of 7.4 and followed by NIR laser irradiation (808nm, 380mW) could accelerate the 
hydrolysis of poly(HPMA-GA). In other words, a much faster hydrolysis of poly(HPMA-GA) 
could be triggered in presence of AuNRs and NIR laser irradiation within a physiologically 



















   Samenvatting en  
Algemene Conclusies 
 
Dit proefschrift handelt over potentiële biomedische toepassingen van drie verschillende 
high aspect ratio nanomaterialen in drie hoofdstukken, die hieronder worden samengevat. 
In Deel I werd een algemene inleiding gegeven om het belang van materiaalwetenschap 
m.b.t. ons dagelijkse leven te bespreken. Hierbij werd voornamelijk de focus gelegd op 
biomedische toepassingen van nanomaterialen met high aspect ratio zoals van koolstof 
afgeleide nanomaterialen (fullerenen, zero-dimensie, carbon nanotube , één -dimensie; 
graphene en graphene oxide, tweedimensionaal; grafiet, driedimensionaal) en polymeer-
gefunctionaliseerde anorganische metaalnanodeeltjes, dwz gold nanorods. 
In Deel II and Deel III werden drie experimentele hoofdstukken gepresenteerd. Structuur, 
grootte, lading, vorm en oppervlaktechemie spelen een sleutelrol m.b.t. de bioactiviteit van 
nanomaterialen.  
Carbon nanotubes (CNTs) zijn hydrofoob en aggregeren makkelijk in waterige media als 
gevolg van de sterke Van der Waals interactiekrachten langs hun lengteas. Vandaar dat voor 
biomedische toepassingen CNT's moeten worden gefunctionaliseerd om wateroplosbaarheid 
en biocompatibiliteit te verschaffen. Verder zou een ideale functionele CNT minimale schade 
aan de CNT-structuur moeten vertonen en over voldoende functionele groepen moeten 
beschikken voor verdere bio-conjugatie. 
In Hoofdstuk I werden drie verschillende batches CNT’s van verschillende commerciële 
bronnen gekozen, met verschillende diameter, lengte en aantal walls. Ultra-sonicatie en 
tanninezuur werden gebruikt om deze CNT's dispergeerbaar in water te maken. Er werd 
SAMENVATTING EN ALGEMENE CONCLUSIES 
176 
 
gevonden dat tanninezuur efficiënt CTN kon stabiliseren, zelfs in afwezigheid van sonicatie. 
ATR-FTIR bewees dat al deze CNT's waren bedekt met tanninezuur. 
Vervolgens onderzochten we het eiwitkoppelingsvermogen van deze CNT-TA en ontdekten 
dat al deze CNT-TA spontaan de modelproteïnen BSA en OVA konden binden. 
Het doel van Hoofdstuk 2 was om het potentieel van graphane oxide (GOx) nanosheets voor 
intracellulaire levering van eiwitten te onderzoeken. GOx nanosheets werden bereid volgens 
een gemodificeerde Hummers-methode en ATR-FTIR en AFM gaven verder bewijs van 
succesvolle vorming van monomoleculaire gelaagde GOx nanosheets die een transparante 
oplossing in water gecombineerden met een high aspect ratio en met hydrofiele functionele 
groepen zoals epoxide, hydroxyl en carbonzuren. 
In tegenstelling tot verschillende andere linker-strategieën waarvan gerapporteerd werd dat 
ze therapeutische moleculen binden aan GOx, hebben we in Hoofdstuk 2 getracht een 
eenvoudige methode te ontwikkelen om vaccinantigenen met GOx nanosheets te formuleren 
zonder de behoefte aan extra reagentia. Bevestigd door ATR-FTIR, SDS-PAGE en 
fluorescentiespectroscopie en microscopie, hebben we waargenomen dat GOx nanosheets 
spontaan kunnen eiwitten kunnen adsorberen. Wanneer gebonden aan GOx nanosheets, 
onderzochten we verder de interactie tussen eiwit (nl. OVA) geladen GOx en dendritische 
cellen in vitro. De verkregen GOx:OVA kan nog steeds worden geïnternaliseerd door 
dendritische cellen en antigen cross-presentation aan CD8 T-cellen bevorderen. Het laatste is 
een kenmerk van de inductie van krachtige cellulaire antigeen-specifieke immuunresponsen 
tegen intracellulaire pathogenen en kanker. 
Afgezien van koolstof-afgeleide multidimensionele nanomaterialen, hebben we in Hoofdstuk 
3 ook met een ander type nanomaterialen met een high aspect ratio, namelijk gold nanorods 
als een externe trigger in combinatie met een polymeer dat upper critical solution 
temperature (UCST) gedrag vertont. In het bijzonder waren we geïnteresseerd in het 
ontwikkelen van een transiently thermoresponsive UCST-polymeer. Een dergelijk polymeer 
zou een soluble-insoluble switch moeten vertonen als reactie op temperatuur, maar 
geleidelijk aan deze eigenschap verliezen ten gevolgd van een hydrolysereactie in het 
polymeer backbone of in de polymeer zijketen. In Hoofdstuk 3 hebben we een volledig 
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synthetische benadering ontwikkeld om een bio-degraderebaar transiently thermoresponsive 
UCST-homopolymeer te synthetiseren, nl. poly (HPMA-glycolamide).  
Hiertoe hebben we een geked biocompatibel polymeer, nl. poly(N-(2-hydroxypropyl) 
methacrylamide) als een scaffold gekozen en de hydroxyl-positie te modificeren met 
glycolamide d.m.v. een afbreekbare carbonaatester verbinding, waardoor HPMA-GA werd 
verkregen. Polymerisatie van HPMA-GA door reversible addition-fragmenattion chain transfer 
(RAFT) polymerisatie resulteerde in een polymeer met een UCST van 42 °C. Verder 
ondergaat, bij een fysiologische pH, wanneer de temperatuur wordt gehandhaafd op de 
fysiologische waarde van 37 °C, het polymeer een overgang van goluble-to-coil ten gevolge 
van hydrolyse van de carbonaatester groepen in de polymeer zijketen. 
Gold nanorods gestabiliseerd door CTAB werden bereid via een one-step seedless methode 
en overgebracht naar de waterige fase d.m.v. dialyse. Vanwege hun high aspect ratio hebben 
deze gold nanorods twee plasmonische pieken, nl. bij 510 nm en 806 nm. Deze AuNR's 
kunnen NIR-licht omzetten in thermische energie. Daarom konden AuNR’s gemengd met 
poly(HPMA-GA) in waterig medium gebufferd bij een pH van 7.4 en in combinatie met NIR 
laserbestraling de hydrolyse van poly(HPMA-GA) versnellen. Met andere woorden, een veel 
snellere hydrolyse van poly (HPMA-GA) kon worden verkregen in aanwezigheid van AuNR's 
en NIR laserbestraling binnen een fysiologisch relevant venster in termen van temperatuur en 
pH. 
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